|
![Spacer Spacer](https://webarchive.library.unt.edu/eot2008/20090117202746im_/http://ott.od.nih.gov/images/point.gif) |
|
Licensing & Royalties |
![spacer spacer](https://webarchive.library.unt.edu/eot2008/20090117202746im_/http://ott.od.nih.gov/images/point.gif) |
|
Licensing Opportunities
Technology Abstracts
|
Devices/Instrumentation- Therapeutics:
Date | Ref. No. | Patent No. | Title |
---|
1/09 | E-234-2008
|
| Method for Predicting and Detecting Tumor Metastasis | 1/09 | E-275-2008 E-275-2008
|
| Use of Mono-Amine Oxidase Inhibitors to Prevent Herpes Virus Infections and Reactivation from Latency | 1/09 | E-182-2008
|
| Method of Treating Pneumoconiosis with Oligodeoxynucleotides | 1/09 | E-278-2007
|
| Attenuated Salmonella as a Delivery System for siRNA-Based Tumor Therapy | 1/09 | E-295-2008
|
| Novel Inhibitor of NF-kappa B Pathway | 12/08 | E-274-2008
|
| Monoclonal Antibodies to the Tumor-Specific Antigen, Human ROR1 | 12/08 | E-003-2008
|
| A Novel, Non-Invasive and Therapeutically Useful High Throughput Technique to Isolate Highly Enriched Tumor Reactive Lymphocytes from Peripheral Blood - Potential Use in Adoptive Immunotherapy | 12/08 | E-310-2008
|
| Discovery of Novel Pharmacophores Inhibiting the Growth of Mycobacterium tuberculosis | 12/08 | E-051-2008
|
| A Novel and Efficient Technology for Targeted Delivery of siRNA | 12/08 | E-007-2008
|
| Method of Promoting Hematopoietic Stem Cell Engraftment by Enhancement of CXCR4 Activity | 12/08 |
| 7,025,961
| Anti-Plasmodium Compositions and Methods of Use (E-004-2004) | 12/08 |
| 7,365,160
| Mutant Nuclear Orphan Receptor for Drug Metabolism Assays | 11/08 | E-256-1999
|
| Methods for Accurately Measuring and Regulating Bound Adrenomedullin | 11/08 |
| 7,349,834
| Molecular Motors Powered by Proteins | 11/08 | E-187-2007
|
| Indoline Compounds for the Treatment of Spinal Muscular Atrophy (SMA) and Other Diseases | 11/08 | E-056-2008
|
| Retinal Pigment Epithelia-Enriched MicroRNAs to Prevent Cell-Differentiation, Proliferation, and Migration | 11/08 | E-145-2008
|
| Compositions and Methods for Inhibition of Fat-Specific Protein 27 | 11/08 | E-088-2006
|
| Ectopic Thymidylate Synthase Accelerates the Development of Hyperplastic Foci and Adenomas in Pancreatic Islets | 11/08 | E-166-2007
|
| Discovery of and Use of Fragments of DOC1 as Antiangiogenic and Antitumor Therapy | 11/08 | E-223-2006
|
| Small-Molecule Modulators of the Thyroid-Stimulating Hormone (TSH) Receptor | 11/08 | E-174-2008
|
| Therapeutic Targeting of CSN5, a Negative Regulator of p53 and p27, in Human Hepatocellular Carcinoma | 11/08 | E-169-2008
|
| Methods for Using Interferon Gamma to Absorb Fluid From the Subretinal Space | 11/08 | E-013-2008
|
| Human Monoclonal Antibodies Against Yersinia pestis | 11/08 | E-331-2007 E-331-2007
|
| Viral Inactivation Using Crosslinkers and Detergents | 11/08 | E-256-2007
|
| Radiation Induced and Targeted Chemotherapy | 10/08 | E-242-2007 E-328-2001
|
| Use of CpG Oligodeoxynucleotides to Induce Epithelial Cell Growth | 10/08 | E-042-2008
|
| Generation of Wild-Type Dengue Viruses for Use in Rhesus Monkey Infection Studies | 10/08 | E-183-2002
|
| Method of Treating Infectious and Inflammatory Lung Disease with Suppressive Oligonucleotides | 10/08 | E-153-2002
|
| Method of Treating and Preventing Infections in Immunocompromised Subjects with Immunostimulatory CpG Oligonucleotides | 10/08 | E-279-2007
|
| Alpha 1-3 N-Acetylgalactosaminyltransferases with Altered Donor and Acceptor Specificities, Compositions, and Methods of Use | 10/08 | E-204-2007
|
| Methods of Glycosylation and Bioconjugation | 10/08 | E-152-2004
|
| Use of Suppressive Oligonucleotides to Treat Uveitis | 10/08 | E-280-2007
|
| Beta 1,4-Galactosyltransferases with Altered Donor and Acceptor Specificities, Compositions and Methods of Use | 10/08 | E-145-2004
|
| Monoclonal Antibodies Against Orthopoxviruses | 10/08 | E-159-2007
|
| Monoclonal Antibodies Against Dengue and Other Viruses With Deletion in Fc Region | 10/08 | E-063-2008
|
| Nanoparticles for Imaging and Treatment of Brain Tumors | 10/08 | E-250-2007
|
| Induced Internalization of Surface Receptors | 10/08 | E-301-2003 E-301-2003
|
| A Method with Increased Yield for Production of Polysaccharide-Protein Conjugate Vaccines Using Hydrazide Chemistry | 10/08 | E-066-2003
|
| Monoclonal Antibodies That Bind or Neutralize Dengue Virus | 10/08 | E-089-2002
|
| Dengue Tetravalent Vaccine Containing a Common 30 Nucleotide Deletion in the 3'-UTR of Dengue Types 1, 2, 3, and 4 | 10/08 | E-230-2002
|
| Catalytic Domains of [beta](1,4)-galactosyltransferase I Having Altered Donor and Acceptor Specificities, Domains That Promote In Vitro Protein Folding, and Methods for Their Use | 9/08 | E-343-2002
|
| gammaPGA Conjugates for Eliciting Immune Responses Directed Against Bacillus anthracis and Other Bacilli | 9/08 |
| 5,762,905 6,685,942
| Human Neutralizing Monoclonal Antibodies to Respiratory Syncytial Virus and Human Neutralizing Antibodies to Respiratory Syncytial Virus | 9/08 | B-056-1994
|
| Murine Monoclonal Antibodies Effective To Treat Respiratory Syncytial Virus | 9/08 |
| 7,361,664
| Vitamin D Receptor Antagonists for Treating Breast Cancer | 9/08 | E-202-2008
|
| Inhibitors of the Plasmodial Surface Anion Channel as Antimalarials | 9/08 | E-027-2005
|
| Novel Chemoattractant-Based Toxins to Improve Vaccine Immune Responses for Cancer and Infectious Diseases | 9/08 | E-324-2004
|
| In Vitro Model for Hepatitis C Virion Production | 9/08 | E-149-2006
|
| Compositions and Methods for Increasing Recombinant Protein Yields through the Modification of Cellular Properties | 9/08 | E-216-2007
|
| Use of Razoxane for the Treatment of Alzheimer's Disease | 9/08 | E-211-2008
|
| Fully Human Anti-Human NKG2D Monoclonal Antibody | 9/08 |
| 7,261,900
| Recombinant Modified Bacillus anthracis Protective Antigen for Use in Vaccines | 9/08 | E-163-2007
|
| Bifunctional Compounds that Bind to Hormone Receptors | 9/08 |
| 7,081,518
| A Novel Recombinant Immunotoxin SS1P (anti-mesothelin dsFv-PE38): A Therapeutic Treatment for Lung Cancer and Other Mesothelin Expressing Cancers | 9/08 | E-323-2008
|
| Matriptase Hypomorphic Mouse Model of a Human Ichthyosis | 9/08 | E-001-1996
|
| Neutralizing Monoclonal Antibodies to Respiratory Syncytial Virus | 9/08 | E-123-2007 E-146-2004
|
| Monoclonal Antibodies that Neutralize B. anthracis Protective Antigen (PA), Lethal Factor (LF) and Edema Factor (EF) | 9/08 | E-153-2005 E-153-2005
|
| Prevention and Treatment of Multiple Sclerosis (MS) by Administering E-Selectin | 9/08 | E-053-2008
|
| Aerosolized Vaccines | 9/08 | E-065-2008
|
| Association of the ECHDCI/RNF146 Gene Region on Human Chromosome 6q with Breast Cancer Risk and Protection | 9/08 |
| 7,419,817
| Scalable Purification of AAV2, AAV4 or AAV5 Using Ion-Exchange Chromatography | 9/08 | E-178-1999 E-178-1999 E-178-1999
|
| Human-Bovine Chimeric Respiratory Syncytial Virus (RSV) Vaccines | 9/08 | E-016-2008
|
| Modified Sugar Substrates and Methods of Use | 9/08 | E-032-2008
|
| Use of Saccharides Cross-Reactive with Bacillus anthracis Spore Glycoprotein as a Vaccine Against Anthrax | 9/08 |
| 6,828,309
| Use of Pentosan Polysulfate to Treat Certain Conditions of the Prostate | 9/08 | E-081-2008
|
| Microfabricated Particles Useful as MRI Contrast Agents | 9/08 | E-147-2008
|
| Cyclized NGR Peptide for Tumor Targeting | 9/08 | E-209-2007
|
| Active Guidewire Visualization Device and System for MRI Guided Intervention | 9/08 | E-069-2008
|
| Methods for the Detection and Treatment of Lung Cancer | 8/08 | E-227-2006
|
| Methods of Preventing Tissue Ischemia | 8/08 |
| 5,668,285
| Total Synthesis of Northebaine, Normorphine, Noroxymorphone Enantiomers and Derivatives via N-Nor Intermediates | 8/08 | E-325-2007
|
| Botulinum Toxoid | 8/08 | E-037-2008
|
| Large Semi-Synthetic Human Antibody Domain Fragment Library | 8/08 | E-140-2008
|
| Species-Independent A3 Adenosine Receptor Agonists | 8/08 | E-159-2008
|
| Polyamine Compounds That Bind Tar RNA of HIV and Methods of Treating Viral Disorders | 8/08 | E-200-1990 E-200-1990 E-259-1994 E-259-1994 E-260-1994 E-062-1996 E-099-1996 E-154-1998 E-256-1998 E-256-1998
|
| Enhanced T-cell Activation by Costimulation: A Potentially Novel Approach for the Prevention and/or Therapy of Cancer (Excluding Prostate Diseases and Melanoma) and for Infectious Diseases | 8/08 | E-072-2008
|
| HIV Immunogen and Method of Making and Using Same | 8/08 | E-175-2008
|
| Over-expression and Mutation of a Tyrosine Kinase Receptor FGFR4 in Tumors | 8/08 | E-043-2008
|
| Cross-Reactive Neutralizing Human Domain Antibody Against HIV-1 | 8/08 | E-332-2007
|
| Small Molecule Inhibitors of c-Met | 8/08 | E-285-2006 E-285-2006 E-285-2006
|
| New Tumor Endothelial Markers: Genes that Distinguish Physiological and Pathological Angiogenesis | 8/08 | E-249-2005
|
| Methods of Treating and Preventing Renal Cancer using a Dimethane Sulfonate Compound | 8/08 | E-141-2003
|
| Monoclonal Antibodies to HIV-1 Vpr | 8/08 | E-057-2002
|
| Conjugates of Ligand, Linker, and Cytotoxic Agent and Related Compositions and Methods of Use | 8/08 | E-194-2008
|
| Immunotoxins Made with Modified Cholix Toxin and Uses Thereof | 8/08 | E-262-2000 E-262-2000
|
| SH2 Domain Binding Inhibitors (E-262-2000) | 8/08 | E-274-2003
|
| 2-Amino-O4-Substituted Pteridines: Improved Chemotherapy Adjuvants | 7/08 | E-282-2007
|
| TGF-beta Gene Expression Signature in Cancer Prognosis | 7/08 | E-101-2004
|
| Treatment of Alcoholism by Inhibition of the Neuropeptide Y Receptor | 7/08 | E-321-2006
|
| Treatment of Skin Conditions Using DKK1 | 7/08 | E-130-2007 E-130-2007 E-130-2007
|
| Steroid Derivatives as Inhibitors of Human Tyrosyl-DNA Phosphodiesterase (Tdp1) | 7/08 | E-121-2008
|
| Protein-tyrosine Phosphotase Inhibitors as Inhibitors of Human Tyrosyl-DNA Phosphodiesterase (Tdp1) and Methods of Treating Disorders | 7/08 | E-218-2007 E-218-2007
|
| A2 Adenosine Receptor Agonists | 7/08 | E-211-2006
|
| Therapeutic Application of Fatty Acid Amide Hydrolase Inhibitors | 7/08 | E-095-2008
|
| A Prophylactic and Therapeutic for Preventing and Treating Tularemia by Rapid Activation of Host Cells and Antigen Recognition | 7/08 | E-150-2007
|
| A Novel Therapeutic Strategy for the Treatment of Hyperpigmentation and Melanoma | 7/08 | E-229-2006
|
| Novel O-GLcNAcase Inhibitor and Fluorogenic Substrate as a Tool for Diagnosing Type 2 Diabetes | 7/08 | E-154-2006
|
| Use of Human Gamma Satellite Insulator Sequences to Prevent Gene Silencing and Allow for Long Term Expression of Integrated Transgenes | 7/08 | E-263-2004
|
| A New Pot1 Variant Gene as a Diagnostic Biomarker for Hereditary Non-polyposis Colorectal Cancer | 7/08 | E-182-2007
|
| Methods for Promoting Stem Cell Proliferation and Survival | 7/08 | E-233-2007
|
| Tendon Stem Cells | 7/08 | E-276-2007
|
| Neutralization of Hepatitis C Virus (HCV) | 7/08 | E-232-2008
|
| Prolactin Receptor Antibodies as a Diagnostic Marker and Therapeutic Agent for Cancer | 7/08 |
| 6,479,286
| Methods and Compositions for Making Dendritic Cells from Expanded Populations of Monocytes and for Activating T Cells | 6/08 | E-245-2006
|
| Novel Isoform of KCNH2 for the Treatment of Schizophrenia | 6/08 | E-292-2007
|
| Immunotoxins with Deletions in Domain II that Remove Immunogenic Epitopes with Minimal Loss of Cytotoxic Activity | 6/08 | E-132-2007
|
| The Combination of Anti-CD22 Immunotoxins with Standard Chemotherapeutic Agents on a Human Burkitt Lymphoma Cell Line | 6/08 | E-309-2006 E-309-2006 E-309-2006
|
| Cell-Nanofiber Composite and Cell-Nanofiber Composite Amalgam Based Engineered Intervertebral Disc | 6/08 | E-198-2003
|
| Construction of Recombinant Baculoviruses Carrying the Gene Encoding the Major Capsid Protein, VP1, From Calicivirus Strains (Including Norovirus Strains Toronto, Hawaii, Desert Shield, Snow Mountain, and MD145-12) | 6/08 | E-116-2005
|
| Cell-Nanofiber Composite Based Engineered Cartilage | 6/08 | E-283-2003
|
| Enzymatically-Active RNA-Dependent RNA Polymerase From a Human Norovirus (Calicivirus) | 6/08 | E-106-2007
|
| Use of Amyloid Proteins as Vaccine Scaffolds | 6/08 | E-214-2003
|
| Construction of an Infectious Full-Length cDNA Clone of the Porcine Enteric Calicivirus RNA Genome | 5/08 |
| 6,320,022 7,101,548
| Treatment and Diagnosis of Cancer, Diabetes and other Disorders Using Adrenomedullin Peptides and Antibodies | 5/08 | E-029-2008 E-029-2008
|
| Human Papillomavirus microRNA Diagnostics and Therapeutics | 5/08 | E-096-2000
|
| The Use of an Inducible Plasmid Vector Encoding for Active TGF-beta for the Treatment of Autoimmune Diseases | 5/08 |
| 7,378,276
| Method of Inducing Memory B Cell Development and Terminal Differentiation | 5/08 | E-080-2008
|
| Human and Improved Murine Monoclonal Antibodies Against CD22 | 5/08 | E-110-2006
|
| Muramyl Dipeptide as a Therapeutic Agent for Inflammation | 5/08 | E-286-2006 E-286-2006
|
| A Novel Growth Factor and Anti-Apoptotic Agent for Promoting Lung Development and Treating Lung Disease | 5/08 | E-129-2008
|
| Synthetic Analogs of Juxtamembrane Domain of IGF-1 Receptor as Anti-Cancer Agents | 5/08 | E-316-2007
|
| Method of Inhibiting ABCG2 and Related Treatments | 5/08 | E-265-2007
|
| Telomerase Suppressor Compositions and Methods for Diagnosis and Treatment of Cancer | 5/08 | E-079-2008
|
| Human Monoclonal Antibody Against Mesothelin | 5/08 | E-012-2008
|
| C4'-Substituted-2-Deoxyadenosine Analogs and Methods of Treating HIV | 5/08 | E-265-1999
|
| Inhibition of Cell Motility, Angiogenesis and Metastasis | 4/08 | E-036-2005
|
| Identification of a Cell-Surface Co-Receptor that Mediates the Uptake and Immunostimulatory Activity of āDā Type CpG Oligonucleotides | 4/08 | E-055-2008
|
| Substituted 3,6-diphenyl-7H-[1,2,4] triazolo[3,4-b] [1,3,4] Thiadiazines as Potent Inhibitors of PDE4A, PDE4B, and PDE4D | 4/08 | E-003-2007
|
| Engineered Human Antibody Constant Domains (Nanoantibodies) as Scaffolds for Binders | 4/08 | E-116-2006 E-306-2006
|
| Influenza Vaccines, Therapeutics, and Monoclonal Antibodies | 3/08 | E-154-2007
|
| VEGF-B as a Therapeutic Agent for Neurodegenerative Disease | 3/08 | E-223-1998
|
| P53 and VGEF Regulate Tumor Growth of NO2 Expressing Cancer Cells | 3/08 | E-064-2008
|
| Epoxy-guaiane Cancer Inhibitors: New Class of Natural Products Isolated from the African Plant Phyllanthus englerii | 3/08 | E-023-2007
|
| Nitrite Adjunctive Therapy to Enhance Efficacy of Reperfusion Therapy for Acute Myocardial Infarction | 3/08 | E-217-2007
|
| N-Acetyl Mannosamine as a Therapeutic Agent | 3/08 | E-239-2007 E-239-2007
|
| PSM Peptides as Vaccine Targets Against Methicillin-Resistant Staphylococcus aureus | 3/08 | E-100-2008
|
| Cell Line PE, Developed From Mouse Skin Tumors, Demonstrates Unique Qualities | 3/08 | E-316-2003
|
| Immunoglobulins with Potent and Broad Antiviral (HIV) Activity Based on scFv Joined by Flexible Linker to Fc | 3/08 | E-247-2002
|
| Modulators of Nuclear Hormone Receptor Activity: Novel Compounds, Diverse Applications for Infectious Diseases, Including Anthrax (B. anthracis) | 3/08 | E-297-2007
|
| Novel Adjuvant Therapy Using TIMP-2 Variants | 2/08 | E-055-2007 E-055-2007 E-055-2007 E-055-2007
|
| Inhibiting HIV Infection Using Integrin Antagonists | 2/08 |
| 7,144,918
| Biologically Active Macrolides, Compositions and Uses Thereof | 2/08 | E-137-2006
|
| Manganese Superoxide Dismutase VAL16ALA Polymorphism Predicts Resistance to Doxorubicin Cancer Therapy | 2/08 |
| 7,196,074
| Preparation and Use of Androgenic Compounds | 2/08 | E-245-2007
|
| An Improved Non Viral System for Tumor Specific Suicide Gene Therapy | 2/08 | E-268-2007
|
| A Fold-Back Diabody Format for Diphtheria Toxin-Based Immunotoxins That Can Increase Binding and Potency | 2/08 | E-017-2008
|
| A Pharmacophore for Isatin-beta-Thiosemicarbazone Compounds with MDR1-Inverse Activity | 2/08 | E-172-2007 E-172-2007 E-172-2007
|
| Collagen-Induced Platelet Aggregation Inhibitor from Mosquito Salivary Glands | 2/08 | E-019-2005
|
| Synergistic Effect of TGF-beta Blockade and Immunogenic Agents on Tumors | 2/08 | E-186-2007
|
| Papilloma Pseudovirus for Detection and Therapy of Tumors | 2/08 | E-162-2007
|
| Ribosomal Protein S3 (RPS3), an Essential Component of NF-kappaB is a Novel and Selective Drug Target | 2/08 | E-208-2007
|
| Eeyarestatins: Novel Deubiquitination Inhibitors for the Treatment of Drug-Resistant Cancers | 2/08 | E-315-2007
|
| New Inhibitors of Multidrug Resistant Proteins Such As ABCG2 | 2/08 | E-116-2004
|
| Coacervate Microparticles Useful for the Sustained Release Administration of Therapeutics Agents | 1/08 |
| 6,274,134
| Antibodies and Polypeptides Specific to AAMP-1: Diagnostic and Therapeutic Uses Thereof | 1/08 | E-108-2007
|
| Photosensitization by Nuclear Receptor-Ligand Complexes and Cell Ablation Uses Thereof | 1/08 | E-241-2006
|
| A Drug Index to Quantify Harmful Drug Exposure in Older Adults | 1/08 | E-008-2008
|
| Diagnosis and Treatment of Barrett's Esophagus and Associated Esophageal Adenocarcinoma | 1/08 | E-153-2007
|
| Nitroxide Radical as a Treatment for Neurodegeneration | 1/08 | E-147-1999
|
| Oligodeoxynucleotide and Its Use To Induce an Immune Response | 12/07 |
| 6,727,079
| cDNA Encoding a Gene BOG and its Protein Product
| 12/07 | E-168-2007
|
| Treatment for Chronic Inflammatory Disease and Cancer by Inhibition of MMP-1 | 11/07 | E-302-2007
|
| A Family of Small Molecules for Selective Inhibition of Wip1 Phosphatase | 11/07 | E-074-2007
|
| Human T-box Transcription Factor Brachyury as a Target for Cancer Immunotherapy: Identification of Epitopes of Human Brachyury as Targets for T-cell Mediated Lysis of Tumors | 11/07 | E-061-2007
|
| Diagnostic Ovarian Cancer Biomarkers | 11/07 | E-177-2006
|
| A Novel, Inhibitory Platelet Surface Protein (TREM Like Transcript, TLT-1): New Target for the Treatment of Cancer, Infectious Diseases, Cardiac Diseases, and Platelet-Associated Disorders | 11/07 |
| 5,583,002 5,556,763 5,889,143 | A New Method for Determining Level of Immunosuppression in Humans | 11/07 | E-146-2007
|
| Selenocysteine Mediated Hybrid Antibody Molecules | 11/07 | E-303-2003 E-135-2006
|
| Inactivation of Enveloped Viruses and Tumor Cells for Infectious Disease and Cancer Vaccines | 11/07 |
| 6,369,235 6,894,068
| Novel Non-Nucleoside Agents for the Inhibition of HIV Reverse Transcriptase for the Treatment of HIV-1 | 10/07 | E-039-2002
|
| Potent HIV-1 Entry Inhibitors and Immunogens | 10/07 | E-187-2003
|
| Quinoline Inhibitors of Retroviral Integrase | 10/07 |
| 7,015,212
| Thiazepine Inhibitors of HIV-1 Integrase | 10/07 | E-264-2006
|
| Integrase Inhibitors for the Treatment of Retroviral Infection Including Human Immunodeficiency Virus-1 | 10/07 | E-308-2005
|
| Discovery of Tropolone Inhibitors of HIV-1 Integrase that can be Used for the Treatment of Retroviral Infection, Including AIDS | 10/07 | E-281-2003
|
| Methods for Identifying Cathepsin G-Related Peptides as Modulators of Formylpeptide Receptors | 10/07 | E-104-2004 E-104-2004
|
| Method for Inducing T-Cell Proliferation | 10/07 | E-084-2007
|
| Use of HDAC Inhibitors for the Prevention and Cure for Brain Metastases of Cancers | 10/07 | E-237-2007
|
| HIV-1 Integrase Inhibitors for the Treatment of Retroviral Infections | 10/07 | E-064-2005
|
| Biomarkers for Tissue Status | 10/07 | E-224-2007
|
| Novel Micro-RNA Sequence Transforms Non-Functional T-Lymphocytes to Highly Functional: Key to Improved Immunotherapy for the Treatment of Cancers | 10/07 | E-213-2007
|
| Flexible, Polyvalent Antiviral Dendritic Conjugates for the Treatment of HIV/AIDS | 10/07 | E-068-2007
|
| Novel Roles of a DNA Repair Protein, DNA-PKcs, in Obesity, Neurological Function, and Aging | 9/07 | E-072-2007
|
| Optically Active Radio-labeled Reverse Transcriptase Inhibitors | 9/07 | E-161-2007
|
| Treatment of Primary Tumors and Tumor Metastases with TNF-alpha Antagonists | 9/07 | E-126-2007 E-174-2007
|
| Suppression of Allergic Asthma by Ascaris Antigens | 9/07 | E-200-2007
|
| New and Improved Chemotherapy Adjuvants: Folate Based Inactivators of O6-alkylguanine-DNA alkyltransferase (alkyltransferase) | 9/07 | E-137-2005
|
| Methods and Compositions for Treating FUS1 Related Disorders | 9/07 | E-050-2007
|
| Methods of Determining the Prognosis of Hepatocellular Carcinoma | 9/07 |
| 6,790,948 7,431,926
| Tumor Suppressor Genes | 9/07 |
| 7,256,256
| Peptide Inhibitor of Cyclin Dependent Kinase 4 (CDK4) Derived from MyoD | 8/07 |
| 6,939,547 7,108,981 7,235,365 | Specific Binding Agents for KSHV vIL-6 that Neutralize a Biological Activity | 8/07 | E-223-2003
|
| Improved Expression Vectors for Mammalian Use | 8/07 | E-282-2002
|
| Methods and Compositions for Treating Diseases and Disorders Associated with Natural Killer T-Cells | 8/07 | E-233-2006 E-233-2006 E-233-2006
|
| Design of Multi-functional RNA Nanoparticles and Nanotubes | 8/07 | E-013-2006
|
| Antiviral Compounds with Broad Neutralization Capabilities | 8/07 | E-080-2006
|
| A New Series of Thalidomide Analogs That Have Potent Anti-Angiogenic Properties | 8/07 | E-104-2006
|
| Immunogenic Peptides and Methods of Use for Treating Prostrate and Uterine Cancers | 8/07 | E-179-2005
|
| Isolation, Cloning and Characterization of New Adeno-Associated Virus (AAV) Serotypes | 8/07 | E-028-1999
|
| Diagnostic and Therapeutic Methods of Detecting and Treating Cancers of Reproductive Tissues | 8/07 | E-215-2007
|
| Methods for Determining Hepatocellular Carcinoma Subtype and Detecting Hepatic Cancer Stem Cells | 8/07 |
| 5,877,179
| Treatment for Cystic Fibrosis Cells and Other Reduced Cl- Conductance Cells | 8/07 | E-306-2006 E-306-2006 E-306-2006 E-306-2006 E-306-2006
|
| Avian Influenza Vaccine | 8/07 |
| 6,685,933 7,235,232
| Interferon Alpha Hybrids | 8/07 | E-249-2006 E-249-2006 E-249-2006
|
| Device and Method for Protecting Against Coronary Artery Compression During Transcatheter Mitral Valve Annuloplasty | 8/07 | E-179-2007
|
| Methods for Prevention and Treatment of Polyomavirus Infection or Reactivation (E-179-2007) | 7/07 | E-181-2007
|
| Rational HIV Therapeutic Design | 7/07 | E-043-1997
|
| Methods for Expression and Purification of Immunotoxins | 7/07 | E-164-2007
|
| Compounds Binding to the N-Terminal Domains of STAT Proteins as Therapeutic Agents | 7/07 | E-059-2006
|
| Method of Treating or Preventing Oxidative Stress-related Diseases (stroke and neurodegenerative diseases, wound healing and cardiovascular diseases) | 7/07 | E-089-2005
|
| Benztropinamine Analogs as Dopamine Transport Inhibitors | 7/07 | E-265-2005
|
| Modification of Recombinant Anti-tumor RNase (rapLR1) for Optimal Use in the Large Scale Manufacture of Stable and Potent RapLR1-Antibody Conjugates | 7/07 | E-151-2006 E-151-2006
|
| Viral Entry or Replication Inhibitors | 7/07 | E-118-2005
|
| A Gene Therapy to Treat Lung Cancer | 7/07 | E-149-2005
|
| Methods and Materials for Identifying Polymorphic Variants, Diagnosing Susceptibilities, and Treating Disease | 7/07 | E-025-2007
|
| Cytochrome P450 Inhibitors for Treatment of Cocaine-Induced Fetal Brain Injury | 7/07 | E-251-2005
|
| Dysphagia Rehabilitation (Swallowing Recovery): Vibro-Tactile Stimulation Device and Method for Motor Control Recovery | 7/07 | E-288-2006
|
| Cyclic Phosphopeptide Inhibitors of Protein Phosphatase 2C Delta, Wip1 | 6/07 | E-088-2007
|
| Zscan4: A Gene Critical for Early Embryonic Development | 6/07 | E-095-2007
|
| A Gene Expression Signature Identifying Pro-Angiogenic Genes in Ovarian Tumor Endothelial Cell Isolates | 6/07 | E-098-2007
|
| Synthetic Macrolides Inhibit Breast Cancer Migration | 6/07 | E-189-2006
|
| Method for the Direct Detection and Quantitation of Asparagine Synthetase in Biological Samples | 6/07 | E-060-2007
|
| A Gene Expression Profile that Predicts Ovarian Cancer Patient Response to Chemotherapy | 6/07 | E-117-2006
|
| Diagnostic and Therapeutic Use of Brother of the Regulator of Imprinted Sites (BORIS) Alternative Splice Forms | 6/07 | E-101-2007
|
| Methods for Prevention and Treatment of Polyomavirus Infection or Reactivation (E-101-2007) | 6/07 | E-144-2004
|
| Monoclonal Antibodies That Bind or Neutralize Hepatitis B Virus | 6/07 | E-120-2007
|
| A Novel Treatment for Non-Small Cell Lung Cancer Using Mesothelin-Targeted Immunotoxins | 6/07 | E-160-2006
|
| Potent, Easy to Use Targeted Toxins as Anti-Tumor Agents | 6/07 | E-121-2007 E-121-2007
|
| A Novel Discriminatory Small Peptide Inhibitor of Hsp90 Targeting Oncogenic Kinases | 6/07 |
| 6,897,018
| DLC-1 Gene Deleted in Cancers | 6/07 |
| 5,167,956 5,725,857 6,632,928 | Immunotoxin with in-vivo T cell Suppressant Activity | 6/07 |
| 5,762,927 5,167,956 6,103,235 | Methods of Inducing Immune Tolerance Using Immunotoxins | 6/07 |
| 5,554,603
| Orally Active Derivatives of 1,3,5(10)-estratriene | 6/07 |
| 6,953,687
| Vectors for Delivering Viral and Oncogenic Inhibitors | 6/07 | E-274-2000
|
| Vibrio cholerae O139 Conjugate Vaccines | 6/07 | E-310-2001
|
| Identification of Ovarian Cancer Tumor Markers and Therapeutic Agents | 6/07 |
| 7,151,087 7,374,872
| CC Chemokine Receptor 5 DNA, New Animal Models and Therapeutic Agents for HIV Infection | 5/07 |
| 7,192,705 7,116,433
| TMC1, a Deafness-Related Gene | 5/07 |
| 7,193,053
| Leu574 of HIF-1alpha as a Molecular Basis for Therapeutic Application | 5/07 | E-110-2004
|
| New Maleiimide Anti-Phosphatase Inhibitors | 5/07 | E-140-2006
|
| A Fullerene-based Anticoagulant | 5/07 | E-018-2005 E-018-2005 E-018-2005
|
| Diagnosing and Treating Cancer Using beta-Catenin Splice Variants | 5/07 | E-133-2006 E-133-2006
|
| New Compounds and Methods for the Treatment of Spinal Muscular Atrophy and Other Diseases | 5/07 |
| 6,818,749 7,256,004
| Humanized Anti-Carcinoma CC49 Monoclonal Antibodies | 5/07 |
| 6,969,609
| Enhanced T-cell Activation by Costimulation: An Effective Immunotherapy for Cancer and Infectious Diseases | 5/07 | E-016-2006 E-287-2004
|
| Novel Diagnostics and Therapeutics for Various Hematologic Malignancies: Monoclonal Antibodies to Members of Fc receptor-like (FCRL) Proteins | 5/07 |
| 5,491,130 5,849,701
| Peptide Inhibitors of Fibronectin and Related Collagen-Binding Proteins | 5/07 | E-070-2005
|
| Inhibitors of Ubiquitin E1 | 5/07 | E-019-2000 E-019-2000 E-019-2000
|
| Inhibition of ABC Transporters by Transmembrane Domain Analogs | 5/07 | E-082-2005 E-082-2005
|
| Sipa-Gene and Sipa-1 Inhibitor for the Diagnosis and Treatment of Metastatic Cancer | 5/07 | E-307-2004
|
| Aminoalkyl Substituted O6-Benzylguanine Derivatives as Inactivators of O6-Alkylguanine-DNA Alkyltransferase and Adjuvants for Chemotherapy | 5/07 | E-056-2004
|
| STAMP, A Novel Cofactor and Possible Steroid Sparing Agent, Modulates Steroid-induced Induction or Repression of Steroid Receptors | 4/07 | E-181-2004
|
| Preparation and Use of Androgenic Compounds: Nandrolone 17beta-carbonates | 4/07 | E-059-2007 E-059-2007
|
| New Mouse T Cell Receptors as Potential Therapeutic Agents for the Treatment of Metastatic Cancer | 4/07 | E-098-2006
|
| Structure of TIM Family Members | 4/07 | E-011-2007
|
| Methods for Treating Autoimmune Inflammatory Disease by Blocking DR3-TL1A Interactions | 4/07 | E-315-2001
|
| RAB38, a Target for Treatment of Melanoma and Pigmentation Disorders | 4/07 |
| 6,753,317 6,916,905
| Novel Dmt-Tic Analogues Specific for Delta- and Mu-Opioid Receptors | 4/07 | E-271-2006
|
| A Novel DNA Vaccine for the Treatment of Malignancies Expressing Immature Laminin Receptor Protein | 4/07 | E-205-2006 E-205-2006
|
| Preparation of (R,R)-Fenoterol and (R,R)-or (R,S)-Fenoterol Analogues and Their Use in Treating Congestive Heart Failure | 4/07 | E-314-2005
|
| Apparatus for Brachytherapy | 4/07 | E-239-2005
|
| Method for Promoting Stem Cell Proliferation and Survival | 4/07 | E-014-2002
|
| Neural Crest-Melanocyte cDNA Based Microarray Analysis for Human Skin Pigmentation Research | 4/07 | E-121-2002
|
| Identification of Anti-HIV Compounds Inhibiting Virus Assembly and Binding of Nucleocapsid Protein to Nucleic Acid | 3/07 |
| 7,217,811 7,189,812
| A Fertility Test to Detect Ovarian Autoimmune Disease Using Human Recombinant MATER Protein | 3/07 | E-126-2006
|
| Novel Benzindole Based Compounds for HIV Therapy | 3/07 | E-148-2003
|
| Genes Expressed in Prostate Cancer and Methods of Use | 3/07 | E-105-2003
|
| Cloning and Characterization of an Avian Adeno-Associated Virus and Uses Thereof | 3/07 | E-314-2003 E-314-2003 E-314-2003
|
| Identification and Isolation of the Receptor for Pigment Epithelium-derived Factor (PEDF) | 3/07 | E-024-2006
|
| Microdialysis Probe for Accessing Tissue in-vivo | 3/07 | E-297-2006
|
| CCR5-Specific Human Monoclonal Antibodies | 3/07 | E-304-2006
|
| Enhanced Function of Gene Modified T-Cells: Identification of T-Cell Receptors (TCR) with Altered Amino Acid Sequence | 3/07 | E-074-1999 E-117-1995
|
| Cyanovirins and Related Conjugates, Compositions, Nucleic Acids, Vectors, Host Cells, Methods of Production and Methods of Use for Microbicide Development | 3/07 | E-035-2005
|
| Potent Activation of Antigen Presenting Cells by the Hepatitis A Virus Cellular Receptor 1 and Its Role in the Regulation of Immune Responses | 3/07 | E-172-2005
|
| Methods of Treating Conditions Characterized by Unwanted or Excessive Presynaptic Neuronal Activity or Secretion | 3/07 | E-323-2004
|
| Arylthioindole Tubulin Polymerization Inhibitors and Methods of Treating or Preventing Cancer Using Same
| 2/07 | E-317-2004
|
| Metal Chelators and Target-Moiety Complexes for Imaging | 2/07 | E-130-2001
|
| Broadly Cross-Reactive Neutralizing Antibodies against Human Immunodeficiency Virus Selected by ENV-CD4-CO-Receptor Complexes | 2/07 | E-070-2007
|
| Human Cancer Therapy Using Engineered Anthrax Lethal Toxin | 2/07 | E-138-2006
|
| Highly Soluble Pyrimido-Dione-Quinoline Compounds: Small Molecules that Stabilize and Activate p53 in Transformed Cells | 2/07 | E-267-2006
|
| A Novel Combination of CXCR-4 Antagonist T22 with Conventional Immunotherapy Improves Treatment Efficacy in Established Tumors | 2/07 |
| 6,562,347
| Methods and Compositions of Chemokine-Tumor Antigen Fusion Proteins as Cancer Vaccines
| 2/07 |
| 6,790,657 7,226,780
| Lentivirus Vector System | 1/07 | E-132-2006 E-132-2006 E-132-2006
|
| A New Method for Improving the Therapeutic Efficacy of L-Asparaginase in Multiple Types of Cancer | 1/07 | E-305-2006
|
| Macrocyclic Grb2 SH2 Domain-Binding Inhibitors: New Anti-cancer and Anti-angiogenic Therapeutic Agents | 1/07 |
| 5,616,471
| Methods for Assaying Hair Follicle Growth and Development | 1/07 |
| 5,420,033
| Epithelial Cell Line Expressing a Cystic Fibrosis Phenotype | 1/07 | E-183-2004
|
| Enriched Natural Killer Cells for Adoptive Infusion Cancer Therapy | 1/07 | E-234-2005 E-234-2005
|
| Novel Benztropine Analogs for Treatment of Cocaine Abuse and Other Mental Disorders | 12/06 | E-295-2005
|
| Novel Treatments for Autoimmune Neuroinflammatory Diseases including Multiple Sclerosis | 12/06 | E-125-2006
|
| Extracellular Matrix/Metastasis Modifier Genes as a Method for Characterization and Prevention of Metastatic Tumor | 12/06 | E-014-2007
|
| Peptide and Peptidomimetic Inhibitors of Smoothened Protein as Anti-neoplastic Agents | 12/06 | E-311-2006 E-311-2006
|
| Chitosan as a Universal Vaccine Adjuvant, Antigen Depot and Cytokine Depot | 12/06 | E-347-2004
|
| ARH3, a Therapeutic Target for Cancer, Ischemia, and Inflammation | 12/06 | E-252-2001
|
| HIV Entry Inhibitor | 11/06 | E-186-2006
|
| Second Generation Nitric Oxide-releasing Non-steroidal Anti-inflammatory Drugs Possessing a Diazeniumdiolate Group (NONO-NSAIDs) | 11/06 | E-200-1998
|
| Methods for Treating Drug-Resistant HIV-1 Infection | 11/06 |
|
| Anti-H5N1 Influenza Activity of the Antiviral Protein Cyanovirin | 10/06 | E-027-2006
|
| PDE11A as a Novel Therapeutic Target for Inherited Form of Cushing Syndrome and Endocrine Tumors | 9/06 | E-200-2006
|
| Mammalian Cell Surface Display of Fvs for Rapid Antibody Maturation | 9/06 | E-271-2005
|
| Novel Treatment of Vascular Cognitive Impairment | 9/06 | E-017-2006
|
| Organic Thiophosphate Antiretroviral Agents | 9/06 |
| 6,635,614
| Use of LCAT to Reduce Cholesterol and Prevent Atherosclerosis | 9/06 | E-262-2003
|
| Methods for Enhancing Beta Cell Function in Diabetes | 09/06 | E-186-2005
|
| Human Protein Tissue Inhibitor of Metalloproteinases-2 (TIMP-2) Derived Anti-Angiogenic Peptides | 9/06 | E-212-2004
|
| Diagnostic and Therapeutic Use of SPANX-N Genes in Cancer and Fertility | 9/06 |
| 7,084,239
| Cancer Peptides of NY-ESO-1/CAG-3 | 8/06 |
| 7,051,737
| Mucus Shaving Apparatus for Endotracheal Tubes | 8/06 |
| 6,706,729
| Novel Thioesters And Uses Thereof | 8/06 | E-336-2001
|
| Amyloid Beta is a Ligand for FPR Class Receptors | 8/06 | E-086-2006
|
| Hybrid T-Cell Receptors for the Development of Improved Vaccines | 8/06 | E-275-2002 E-275-2002
|
| Adoptive T-Cell Transfer After Lymphodepletion Promotes Tumor Regression | 8/06 | E-329-2000
|
| Novel Acylthiol Compositions and Methods of Making and Using Them | 8/06 | E-042-2006
|
| Complement Regulatory Gene Variants as Predictive Tests for Age-related Macular Degeneration (AMD) | 8/06 |
|
| Use of Grape Skin Extracts as Anti-Cancer Agents | 8/06 | E-166-2006
|
| A Novel Small Protein Antibiotic | 8/06 | E-201-2006
|
| Diagnostic and Therapeutic Strategies for Metastatic Hepatocellular Carcinoma by Targeting Osteopontin | 8/06 | E-180-2006
|
| Neutralizing Monoclonal Antibodies to Botulinum neurotoxin A | 8/06 | E-074-2005
|
| The Mucus Slurper: A Novel Device to Keep the Endotracheal Tube (ETT) Free of All Mucus, Without Suctioning | 8/06 | E-340-2004 E-340-2004
|
| Adoptive Immunotherapy with T Lymphocytes Engineered for Enhanced Survival | 7/06 | E-017-2004
|
| Methods and Compositions Related to GHS-R Antagonist | 7/06 | E-335-2005
|
| Fluorescent Imaging and Photodynamic Treatment of Tumors | 7/06 | E-136-2006
|
| Method for Expanding Allodepleted Antigen Specific T Cells | 6/06 | E-090-2004
|
| Radio-Activated Boron-Nitride Nanotube-Antibody Conjugates for Cancer Therapy and Diagnostics | 6/06 | E-165-2006
|
| Diamidine Inhibitors of Tdp1 as Anti-Cancer Agents | 6/06 | E-091-2004
|
| Ultrasonic Waves with Nanovessels or Tethered Nanotube/Monoclonal Antibody Composites for Cancer Therapy | 6/06 | E-010-2005
|
| Generation of Regulatory T Cells for Immunotherapy | 6/06 | E-097-2006
|
| Use of Tetracyclines as Anti-Cancer Agents | 6/06 | E-122-2006
|
| Agonist Epitopes for Renal Cell Carcinoma | 6/06 | E-336-2005
|
| Novel Human IGF-1 Specific IGF-I and IGF-II Cross-Reactive Human Monoclonal Antibodies as Potential Anti-tumor Agents | 6/06 | E-108-2005
|
| Treatment of Inflammatory Bowel Disease (IBD) using NF-KB Decoy Polynucleotides | 6/06 | E-003-2005
|
| Treatment and Prevention of Inflammatory Bowel Disease (IBD) using Mutant and Chimeric IL-13 Molecules | 6/06 |
| 6,982,168
| Immortal Human Prostate Epithelial Cell Cultures as a Prostate Cancer Model | 5/06 | E-031-2003
|
| Immunogenic Epitopes for Fibroblast Growth Factor-5 (FGF-5) Presented by HLA-A3 and HLA-A2 | 5/06 | E-039-2004 E-039-2004 E-039-2004 E-039-2004
|
| Peptide Inhibitors of HIV-1 Integrase Useful for the Treatment of Retroviral Infection and HIV | 5/06 | E-114-2003
|
| Methods and Compositions for the Inhibition of HIV-1 Replication | 5/06 | E-265-2003
|
| Methods for Inhibiting HIV and Other Viral Infections by Modulating Ceramide Metabolism | 5/06 | E-075-2003
|
| Use of Cripto-1 as a Biomarker for Neurodegenerative Disease and Method of Inhibiting Progression Thereof | 5/06 | E-106-1994
|
| Novel Bis-Acridones As Anti-Tumor Agents: Potential For Treating Drug Resistant Tumors | 5/06 | E-106-2006
|
| T-cell Receptor Recognizing Renal Cell Carcinoma | 5/06 |
| 6,680,176
| Identification of Candidate Ligands which Modulate Antigen Presenting Cells | 5/06 | E-305-2005
|
| Potent Pharmacophoric Delta- and Mu-Opioid Receptor Antagonists and Conversion of Endomorphin Mu-Opioid Agonists to Antagonists | 5/06 | E-200-2005
|
| Insect Cell Production of Recombinant Adeno-Associated Virus that Produce Cytotoxic Gene Products and Applications for Solid Tumor Therapy | 5/06 | E-139-2005
|
| Identification of a Novel Folliculin Interacting Protein, FNIP-1 | 5/06 | E-196-2004
|
| Bone Morphogenetic Variants, Compositions and Methods of Treatment | 5/06 | E-094-2006
|
| Preparation of a Peptide Targeted Human RNase, RGD-Eosinophil Derived Neurotoxin (RGD-EDN) To Specifically Target Tumor Vasculature | 5/06 | E-090-2006 E-090-2006
|
| Adoptive Immunotherapy with Autologous Natural Killer Cells | 5/06 | E-176-1998
|
| Anti-Notch-1 Monoclonal Antibodies for Inducing Cellular Differentiation and Apoptosis | 3/06 |
| 6,984,379
| Gene Therapy by Administration of Genetically Engineered CD34+ Obtained by Cord Blood | 3/06 | E-319-2005
|
| Methods of Treating Cancer Using Pyridine Carboxaldehyde Pyridine Thiosemicarbazone Radiosensitizing Agents | 3/06 | E-262-1999
|
| Monoclonal Antibodies Which Specifically Bind to the Ligand Hepatocyte Growth Factor (HGF) and are Useful in the Treatment of Cancer | 3/06 | E-128-2005
|
| Rapid Methods for Human Artificial Chromosome (HAC) Formation | 3/06 | E-312-2005
|
| Immunogenic Peptides and Methods of Use for Treating and Preventing Cancer | 3/06 | E-254-2003
|
| Treatment of Pulmonary Hypertension (PH) Using Nitrite Therapy | 3/06 | E-263-2003
|
| Immunogenic T Cell Targets in Autoimmune Hepatitis and Methods of Use | 3/06 | E-051-2006
|
| Deoxyhypusine Hydroxylase | 3/06 | E-208-2003
|
| TNF-alpha Converting Enzyme Inhibitory Agents and Stimulatory Agents | 3/06 | E-184-2001
|
| Modified Growth Hormone | 2/06 |
| 6,100,555 6,989,263
| The CCHC Zinc Fingers of the Retroviral Nucleocapsid Protein Comprises a New Target Useful in Identification and Evaluation of Anti-HIV Therapeutics | 2/06 |
| 6,060,458
| Oligodeoxyribonucleotides Comprising O6-Benzylguanine and Their Use | 2/06 | E-065-2002
|
| ELISA Assay of Serum Soluble CD22 to Assess Tumor Burden/Relapse in Subjects with Leukemia and Lymphoma | 2/06 |
| 6,294,322
| Multideterminant Peptides That Elicit Helper T-Lymphocyte Cytotoxic T-Lymphocyte and Neutralizing Antibody Responses Against HIV-1 | 2/06 | E-025-2006
|
| Anti-Viral Griffithsin Compounds, Compositions, and Methods of Use | 2/06 | E-218-2005
|
| Methodology for Large Scale Manufacture of Stable Disulfide-Conjugated Antibody-Ribonuclease | 2/06 | E-175-2004
|
| Rapid Anti-Depressant Response Produced by Low Dose Treatment with Anti-Muscarinic Drugs | 2/06 | E-296-2004
|
| Novel Form of Interleukin-15, Fc-IL-15, and Methods of Use | 2/06 |
| 5,976,541
| Potent Peptide for Stimulation of Cytotoxic T Lymphocyte Specific for the HIV-1 Envelope | 2/06 | E-106-2005
|
| Identification of Biomarkers by Serum Protein Profiling | 2/06 |
| 6,040,334
| Use of Inhibitors of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase as a Modality in Cancer Therapy | 1/06 | E-298-2004
|
| Transcytosis of Adeno-Associated Viruses | 1/06 | E-163-2005
|
| Intraperitoneal Injection of Pseudovirions Carrying a Toxin Leads to Significantly Reduced Tumor Size | 1/06 | E-014-1991
|
| Pharmaceutical Compositions and Methods for Preventing Skin Tumor Formation and Causing Regression of Existing Tumors | 1/06 | E-067-1995
|
| Treatment of Hyperproliferative Epithelial Skin Diseases by Topical Application of Hydroxylated Aromatic Protein Cross-Linking Compounds | 12/05 | E-058-2005
|
| Synthesis of Indenoisoquinoliniums and Methods of Use | 12/05 | E-142-2005
|
| A Single Ribozyme to Catalyze both Trimming and Transacting Catalysis - Potential Therapeutic for HPV Infection and Cervical Cancer | 12/05 | E-133-2005
|
| Genomic Nucleic Acid Sequence for Cyanovirin-N and Signal Peptide Thereof | 12/05 | E-253-2005
|
| Methods and Compositions for the Inhibition of SARS-CoV Replication Propagation and Transmission | 12/05 | E-323-2003
|
| Minimally Immunogenic Variants of SDR-Grafted Humanized Antibody CC49 and Their Use | 12/05 | E-003-2006
|
| Antibodies and Immunotoxins that Target Human Glycoprotein NMB | 12/05 | E-142-1990
|
| Autotaxin: Motility Stimulating Protein Useful in Cancer Diagnosis and Therapy | 12/05 | E-205-1999
|
| Bisubstrate Inhibitors of Acetyltransferases | 11/05 | E-217-2005
|
| Antibodies Against Insulin-Like Growth Factor II and Uses Thereof | 11/05 | E-104-2005
|
| Furin Inhibitors and Alpha-Defensin for Preventing Papilloma Virus Infection | 11/05 | E-051-2005
|
| Identification of a Fusion/Entry Receptor for Human Herpesvirus-8 | 11/05 | E-192-2004
|
| Compositions and Methods for Diagnosis and Treatment of Chemotherapy-Resistant Neoplastic Disease | 11/05 | E-272-2002 E-272-2002
|
| Serine Protease Inhibitors | 10/05 | E-081-2001 E-081-2001 E-081-2001
|
| Zebularine, A Stable and Orally Active Inhibitor of Cytosine DNA Methyltransferase Capable of Reactivating Dormant Tumor Suppressor and Inhibiting Tumor Growth | 10/05 | E-065-2005
|
| Novobiocin Analogues as Anticancer Agents | 10/05 |
| 5,272,146 5,441,941
| 1,2-Dihydroellipticines with Activity Against CNS-Specific Cancer Cell Lines | 10/05 | E-167-1997
|
| The Use of Nitroxides in the Prophylactic and Therapeutic Treatment of Cancer Due to Genetic Defects | 10/05 |
| 6,428,788
| Compositions and Methods of Specifically Targeting Tumors | 10/05 |
| 6,984,517
| AAV5 Vector and Uses Thereof | 10/05 | E-262-2005
|
| Mutated Pseudomonas Exotoxins with Reduced Antigenicity | 9/05 | E-211-2005
|
| Inhibitors of the Protein Kinase Chk2 to Abrogate Apoptosis and Sensitize Cancer Cells to DNA Targeted Therapies | 9/05 | E-121-2005
|
| Polymer-linked Pseudomonas Exotoxin Immunotoxin | 9/05 | E-087-1996
|
| Heterologous Boosting Immunizations | 9/05 | E-181-1999
|
| A Combined Growth Factor-Deleted and Thymidine Kinase-Deleted Vaccinia Virus Vector for Cancer Therapy | 9/05 | E-095-2000
|
| Amelioration of Inflammatory Arthritis Targeting the Pre-ligand Assembly Domain (PLAD) of Tumor Necrosis Factor Receptors | 9/05 |
| 5,217,953 5,565,424 6,630,124 | Cancer Therapy Using Vasoactive Intestinal Peptide Antagonists | 9/05 | E-144-2005
|
| Soluble Fragments of the IGF1R Ectodomain | 9/05 | E-327-2004
|
| A New Approach Toward Macrocyclization of Peptides | 9/05 | E-105-2002
|
| Regulation of INS (3456) P4 Signaling by a Reversible Kinase/Phosphatase and Methods and Compositions Related Thereto | 9/05 | E-243-2002 E-243-2002
|
| Recombinant Vaccinia Viruses Expressing IL-15 and Methods of Using the Same | 9/05 | E-312-2003
|
| Methods for Treating Viral-Associated Tumors with LFA-1 Inhibiting Statins | 9/05 |
| 6,943,191
| Disubstituted Lavendustin A Analogs and Pharmaceutical Compositions Comprising the Analogs | 9/05 | E-291-2003
|
| New Building Blocks for DNA Binding Agents | 9/05 | E-244-1997 E-244-1997
|
| Antitumor Macrocyclic Lactones / Vacuolar-Type (H+)-ATPase-Inhibiting Compounds and Uses Thereof | 9/05 |
| 6,136,992
| Novel 2-Alkoxy Estradiols and Derivatives Thereof | 9/05 | E-060-2002
|
| DNA-Binding Polyamide Drug Conjugates | 9/05 | E-315-2003
|
| SH2 Domain Binding Inhibitors (E-315-2003) | 8/05 |
| 7,163,818
| Bacteriophage Having Multiple Host Range | 8/05 | E-318-2000
|
| Method for Determining Sensitivity to a Bacteriophage | 8/05 | E-236-2002
|
| Design of a Novel Peptide Inhibitor of HIV Fusion that Disrupts the Internal Trimeric Coiled-coil of gp41 | 8/05 | E-302-2004
|
| A32 Monoclonal Antibody Fusion Protein for Use as HIV Inhibitors and Vaccines | 8/05 | E-140-2005
|
| Induction of C/EBPalpha and Uses Thereof | 8/05 |
| 5,861,156
| Methods of Delivering Agents to Target Cells | 8/05 | E-235-2004
|
| Inhibition of SMAD-Signaling Leads to Enhanced Insulin Production and Better Glucose Control: A Potential Therapy for Diabetes and Associated Complications Due to Hyperglycemia | 8/05 | E-092-2004
|
| Anti-Marinobufagenin Antibodies and Methods for Their Use | 8/05 | E-047-2005
|
| North-2'-Deoxy-Methanocarbathymidines as Antiviral Agents Against Poxviruses | 8/05 | E-046-2005
|
| A Novel Interleukin-12 (IL-12) Inducing Protein Isolated from Toxoplasma gondii Inflammatory Profilin (TGIP) | 8/05 | E-083-2002
|
| Use of Discoidin Domain Receptor 1 (DDR1) and Agents that Affect the DDR1/Collagen Pathway | 8/05 | E-180-2005
|
| Scytovirin Domain 1 (SD1) Related Polypeptide | 8/05 | E-137-2003
|
| Vaccines and Methods of Treating Drug-Resistant HIV-1 and Hepatitis B Viruses | 8/05 | E-155-2005 E-155-2005 E-155-2005 E-155-2005
|
| Immunogenic Peptides From Human Papillomavirus Type 16 E2 | 8/05 | E-131-2000
|
| Methods for Reducing Tumor Growth and Metastasis by Inhibiting MCP-1 Activity | 7/05 |
| 5,792,752 5,902,794
| Use of 8-C1-cAMP as Anticancer Drug | 7/05 | E-208-2005
|
| Anti-CD30 Antibodies that Bind to Intact CD30 but not to Soluble CD30 | 7/05 |
| 7,052,907
| Adult Human Dental Pulp Stem Cells in vitro and in vivo | 7/05 |
| 6,812,246
| Aminoflavone Prodrug | 7/05 | E-075-2004 E-075-2004 E-075-2004
|
| Methods for the Identification and Use of Compounds Suitable for the Treatment of Drug Resistant Cells | 7/05 | E-033-2004
|
| Multipotent Postnatal Stem Cells From Human Periodontal Ligament and Uses Thereof | 7/05 | E-018-2003
|
| Postnatal Stem Cells and Uses Thereof | 6/05 | E-320-2001
|
| Compositions and Methods for Inhibiting Vascular Channels and Methods of Inhibiting Proliferation | 6/05 | E-135-2002 E-135-2002
|
| Novel Anti-CD30 Antibodies and Recombinant Immunotoxins Containing Disulfide-Stabilized Fv Fragments | 6/05 |
| 6,153,421 7,201,911
| Cloned Genomes Of Infectious Hepatitis C Virus And Uses Thereof | 6/05 | E-018-2005
|
| Method of Diagnosing and Treating Cancer Using beta-Catenin Splice Variants | 6/05 | E-138-2005
|
| Infectious Particle Composition and Methods of Use Thereof | 6/05 | E-339-2004
|
| Framework Residue Substituted Humanized COL-1 Antibodies and Their Use | 6/05 | E-188-2004
|
| Therapeutic Delivery of Nitric Oxide From Novel Diazeniumdiolated Derivatives of Acrylonitrile-based Polymers | 6/05 | E-106-2004
|
| Compositions Comprising T Cell Receptors and Methods of Use Thereof | 6/05 | E-158-2005
|
| Identification of H2-Db and HLA-A2 Specific CD8 Epitopes from Human KDR/VEGFR-2 that Inhibit Angiogenesis by Vaccination | 6/05 | E-121-2004
|
| A New Antiviral Pathway that is Responsible for Viral Clearance: Modulation of ADAR1 Activities Enhance Antiviral Therapies and Virus Infection of Tissue Culture Systems | 6/05 | E-271-2003 E-271-2003
|
| Epitopes of Ebola Virus Glycoproteins Useful for Vaccine Development | 6/05 | E-302-2003
|
| Inhibiting IL-13 Receptor-Expressing Cancer Cells with Anti-IL-13 Receptor Immunotoxin and Alkylating Agents | 6/05 | E-043-2005
|
| Cell Culture System for Efficient Expression of Self-Replicating Norwalk Virus | 5/05 | E-069-2005
|
| Mammary Gland Differentiation by 2-Methoxyestradiol | 5/05 | E-199-1999
|
| Mycolactone and Related Compounds | 5/05 | E-279-2004
|
| Treatment of Human Viral Infections (Resveratrol) | 5/05 | E-281-2004
|
| Treatment of Human Viral Infections (Imatinib) | 5/05 | E-280-2004
|
| Treatment of Human Viral Infections (Proteosome Inhibitors) | 5/05 | E-282-2004
|
| Treatment of Human Viral Infections (Farnesyl Transferase Inhibitors) | 5/05 | E-330-2004
|
| Synthesis of Phosphocholine Ester Derivatives and Conjugates Thereof | 5/05 | E-245-2004
|
| Methods of Reducing the Activity and Concentration of an Eph Receptor Tyrosine Kinase | 5/05 | E-272-2003
|
| Analogs of Thalidomide as Potential Angiogenesis Inhibitors | 5/05 | E-295-2002
|
| Lepirudin Adsorbed to Catheter | 4/05 |
| 7,303,754
| MVA Expressing Modified HIV envelope, gag, and pol Genes | 4/05 | E-263-2002 E-263-2002
|
| Peptide Inhibitors of Yersinia Phosphatase (YopH) as Potential Treatments Against Plague | 4/05 | E-356-2003
|
| Chimeric HIV/SIV Polypeptide Trimers as HIV/AIDS Vaccine Candidates | 4/05 | E-190-2002
|
| Identification of Novel Birt-Hogg-DubƩ (BHD) Gene | 4/05 | E-150-2001
|
| Use of a Promoter of T-cell Expansion and an Inducer of CD40 Stimulation in the Treatment or Prevention of a Pathologic State | 4/05 |
| 6,916,843
| Endothelial Protective Actions of Cytochrome P450 Epoxygenase-derived Eicosanoids | 4/05 | E-176-2003
|
| Antibodies Against the Amino Terminus Region of Circumsporozoite Protein Prevent the Onset of Malaria | 4/05 | E-160-2004
|
| Methods for Inhibiting or Treating Cancer | 4/05 | E-226-2004
|
| Metastasis Suppressor Gene on Human Chromosome 8 and Its Use in the Diagnosis, Prognosis and Treatment of Cancer | 4/05 | E-104-1999
|
| T-Cell Receptor Alternate Reading Frame Protein, (TARP) and Uses Thereof | 4/05 | E-343-2004
|
| Use of Targeted Bone Marrow Cell Infiltration to Induce Pigmentation and Hair Growth in Skin | 4/05 | E-107-2005
|
| Methods for Tumor Treatment Using Dendrimer Conjugates | 4/05 | E-117-2005
|
| Aminoglycosides and Ribosome Inhibitors as Inhibitors of Tyrosyl-DNA-Phosphodiesterase | 4/05 |
| 6,797,492
| Method for Reducing the Immunogenicity of Antibody Variable Domains | 4/05 |
| 6,255,104 6,342,392 6,737,251 | Nucleotide and Deduced Amino Acid Sequences of a New Tumor Gene, Int6 | 4/05 | E-333-2004
|
| HIV Neutralization by Structure-Based Enhancements of CD4-Molecular Mimicry | 4/05 | E-358-2004
|
| Triptolide to Induce Immunotolerance | 4/05 | E-127-2005
|
| Composition and Methods for Diagnosis and Treatment of Metastatic Disease | 4/05 | E-072-2005
|
| Inhibition of Proteosome Function to Potentiate the Proapoptotic and Antitumor Activity of Cytokines | 4/05 | E-318-2004
|
| Regulation of ATG7 Beclin 1 Program of Autophagic Cell Death by Caspase-8 | 4/05 |
| 5,104,977 5,656,587 5,705,477 | Compositions of Transforming Growth Factor Beta (TGF-beta) Which Promotes Wound Healing and Methods for Their Use | 3/05 | E-105-2004 E-105-2004
|
| Minimally Immunogenic Germline Sequence Variants of COL-1 Antibody and Their Use | 3/05 | E-001-2005
|
| Carbohydrate-Encapsulated Gold Nanoparticles as Novel Anti-Metastatic Agents | 3/05 | E-281-1999 E-281-1999
|
| Tyrosyl-DNA Phosphodiesterases (TDP) and Related Polypeptides, Nucleic Acids, Vectors, TDP-Producing Host Cell, Antibodies and Methods of Use | 3/05 |
| 5,610,053
| Chromatin Insulator Protecting Expressed Genes of Interest for Human Gene Therapy or Other Mammalian Transgenic Systems | 3/05 | E-079-2005
|
| Inhibition of Human Papillomavirus Type 16 and 18 E6 and E7 Oncogene Expression by E6 and E7-specific siRNAs | 3/05 | E-215-2004
|
| CpG Oligonucleotide Prodrugs | 3/05 | E-076-2004
|
| An Epitope-Enhancement of Human CD4 HIV Epitope | 3/05 | E-101-2005
|
| Karyotypic Complexity as a Determinant of Anti-Cancer Drug Activity | 3/05 | E-251-2004
|
| Broadly Cross-Reactive HIV-1 Neutralizing Human Monoclonal Antibodies | 3/05 | E-037-2005
|
| Dimer Inhibitory Peptides of CXCR4 as a Possible Novel Therapy for Cancer | 3/05 |
| 4,942,184
| Water-Soluble, Antineoplastic Derivatives of Taxol | 3/05 | E-196-1998
|
| Cannula for Pressure Mediated Drug Delivery | 3/05 | E-160-2002
|
| Tryptophan as a Functional Replacement for ADP-ribose-arginine in Recombinant Proteins | 3/05 | E-010-2004
|
| Modulating P38 Kinase Activity | 2/05 | E-328-2004
|
| Methods for Treating Active Uveitis | 2/05 | E-025-2003 E-025-2003
|
| Methods for Prophylaxis and Treatment of HER-2/neu Tumors | 2/05 | E-204-2001
|
| Rapid, Efficient In Vivo Site-Directed Mutagenesis Using Oligonucleotides | 2/05 | E-355-2004
|
| Compositions and Methods for the Treatment of Immune-Related Disease | 2/05 | E-094-2003
|
| A Novel, Preservative-Free Steroid Formulation for Use as an Anti-Inflammatory | 2/05 | E-226-2003
|
| Novel Potent Monoamine Oxidase Inhibitors | 2/05 | E-248-2004
|
| A3 Adenosine Receptor Agonists | 1/05 | E-237-2004
|
| Closed-Circuit Flow Obturator for Laparoscopy Port | 1/05 | E-102-2004
|
| Treatment of Inappropriate Immune Responses | 1/05 | E-244-2004
|
| The UBE2G2 Binding Domain in the Ubiquitin Ligase GP78 and Methods of Use Thereof | 1/05 | E-131-2002
|
| A Method of Treating Inflammatory Bowel Disease (IBD) | 1/05 | E-130-2004
|
| Novel Methods for Reducing Inflammation and Treating Diseases such as Parkinsonās and Alzheimerās Disease | 1/05 | E-259-2003
|
| Anti-Proliferative Activity of an Unexpected mTOR Kinase Inhibitor | 1/05 | E-116-2003
|
| Immunogenic Peptides for the Treatment of Prostate and Breast Cancer | 1/05 | E-172-2004
|
| Novel Compounds and Methods for Treating Alzheimerās and Related Diseases | 1/05 | E-287-2004 E-287-2004
|
| Mabs to IRTA2 for Use in Diagnosis and Therapy of IRTA-Expressing Cancers | 1/05 | E-123-2001 E-124-2001
|
| Peptide Agonists of Prostate-Specific Antigen and Uses Thereof | 1/05 | E-208-2002
|
| Applications for the HMGN1 Pathway | 1/05 | E-084-2003
|
| Detection of Antigen-Specific T Cells and Novel T Cell Epitopes by Acquisition of Peptide/HLA-GFP Complexes | 1/05 | E-191-2003
|
| Eosinophil-Derived Neurotoxin, an Antimicrobial Protein with Ribonuclease Activity, is an Immunostimulant | 1/05 | E-051-2003
|
| Recombinant Immunotoxin and Use in Treating Tumors | 1/05 | E-331-2002
|
| Activation of Recombinant Diphtheria Toxin Fusion Proteins by Specific Proteases Highly Expressed on the Surface of Tumor Cells | 1/05 | E-073-2003 E-073-2003
|
| Protein Kinase C Inhibitor, Related Composition, and Method of Use | 12/04 | |
| Adoptive Immunotherapy with Enhanced T-Lymphocyte Survival | 12/04 | E-095-2004
|
| Novel Compounds That Release Both Nitric Oxide (NO) and Nitroxyl (HNO) As Pharmacological Agents | 12/04 | E-332-2004
|
| The Use of Rabbits with Defined Immunoglobulin Light Chain Genes (Ckappa b allotypes) to Optimize Production of Chimeric and Humanized Monoclonal Antibodies for Therapeutic, Imaging and Diagnostic Applications | 12/04 | E-004-2005
|
| Human Monoclonal Antibodies Against Hendra and Nipah Viruses | 12/04 |
| 6,855,314
| AAV5 Vector for Transducing Brain Cells and Lung Cells | 12/04 |
| 6,468,524
| AAV4 Vector and Uses Thereof | 12/04 |
| 7,238,473
| TTP as a Regulator of GM-CSF mRNA Deadenylation and Stability | 12/04 | E-299-2004
|
| Vaccines Against Crimean-Congo Hemorrhagic Fever | 12/04 | E-257-2004
|
| Modulating Expression of the Metastasis Suppressor MxA | 11/04 | E-233-2004 E-233-2004
|
| Anti-HIV Peptide Secreting Bacteria: Therapeutics and Methods of Use | 11/04 | E-178-2004 E-178-2004
|
| Infectious Clone of Human Parvovirus B19 and Methods of Use | 10/04 | E-256-2004
|
| Inhibitors of HIV Ribonuclease H Antiviral Properties | 10/04 | E-062-2003
|
| Use of Smad3 Inhibitor in the Treatment of Fibrosis Dependent on Epithelial to Mesenchymal Transition as in the Eye and Kidney | 10/04 | E-220-1993 E-039-2003
|
| Method for Inhibiting Angiogenesis
and
Combinatorial Therapy for Protein Signaling Diseases | 10/04 | E-059-2004
|
| Multimeric Protein Toxins to Target Cells Having Multiple Identifying Characteristics | 10/04 | E-342-2004
|
| Mouse Monoclonal Antibody (4G11) Against Insulin-Like Growth Factor I Receptor | 10/04 | E-272-2004
|
| Protozoan Derived Antagonist of CCR5 | 10/04 |
| 7,303,751
| Anti-Plasmodium Compositions and Methods of Use (E-049-2004) | 10/04 | E-070-2000
|
| Inhibition of Smad3 to Prevent Fibrosis and Improve Wound Healing | 9/04 | E-311-2003
|
| Use of Protein Kinase C Delta Inhibitor, Specifically Rottlerin, Alone or in Further Combination with Staurosporine, in the Treatment of Metastatic Epithelioid Melanoma | 9/04 | E-312-2000 E-312-2000 E-312-2000
|
| Hybrid Adeno-Retroviral Vector for the Transformation of Cells (E-312-2000) | 8/04 |
| 6,734,014
| Methods and Compositions for Transforming Dendritic Cells and Activating T Cells | 8/04 |
| 6,723,551 7,271,002
| Production of Adeno-Associated Viruses in Insect Cells | 8/04 | E-007-2004
|
| Adduct Compounds of Pyrrolobenzodiazepinones, Compositions Comprising the Same and Methods Related Thereto | 8/04 | E-211-2003
|
| A Combined Immunosuppressive Therapy Consisting of Glucocorticoid and rIL-2 | 8/04 |
| 6,696,436
| B-Homoestra-1,3,5(10)-trienes as Modulators of Tubulin Polymerization | 8/04 | E-106-2003
|
| Griffithsin, Glycosylation-Resistant Griffithsin, and Related Conjugates, Compositions, Nucleic Acids, Vectors, Host Cells, Methods of Production and Methods of Using | 8/04 | E-254-2003
|
| Methods of Use of Nitrite Therapy | 8/04 | E-074-2004
|
| Methylation Inhibitor Compounds | 8/04 | E-056-2003 E-056-2003
|
| Human Neuronal Cells for Therapeutic Uses | 8/04 | E-013-2003
|
| Activation of Nerve Growth Factor Receptor Trophic Functions | 7/04 | E-090-2003
|
| Vaccine Peptide Derived from XAGE-1 to Prevent Tumor Growth | 6/04 | E-035-2004 E-035-2004 E-035-2004 E-035-2004
|
| Stem Cell Factor (SCF) Stimulates Neural Stem Cell Migration to Sites of Brain and Spinal Cord Injury | 6/04 | E-325-2002
|
| Antibodies That Bind POTE and Uses Thereof | 6/04 |
| 5,635,599 6,011,002
| Circularly Permuted Ligands and Circularly Permuted Fusion Proteins | 6/04 | E-335-2003 E-335-2003
|
| Mechanisms for Improving the Breadth of the Immune Response to Diverse Strains and Clades of HIV | 6/04 | E-150-2004
|
| A Peptide that Elicits Neutralizing Antibodies Targeting the HIV Co-Receptor CCR5 | 6/04 | E-165-2004
|
| SARS Coronavirus MVA Vaccines and Therapy | 6/04 | E-278-2003
|
| Interferon-Alpha SARS Treatment | 6/04 | E-016-2004
|
| Methods for Inhibiting Proinflammatory Cytokine Expression Using Ghrelin | 6/04 | E-334-2003 E-334-2003 E-334-2003
|
| Enhanced Sensitivity ELISA for SARS Diagnostic | 6/04 |
| 5,652,223 5,981,712
| DNA Encoding CAI Resistance Proteins and Uses Thereof | 6/04 | E-228-2003 E-228-2003
|
| Soluble SARS Coronavirus Spike Protein (S Protein) | 5/04 | E-004-02/0 E-004-2002
|
| Cloning and Mutational Analysis of the Hyperparathyroidism-Jaw Tumor Syndrome (HPT-JT) Gene | 5/04 | E-125-2002 E-125-2002
|
| Methods of Diagnosing Potential for Developing Hepatocellular Carcinoma or Metastasis and of Identifying Therapeutic Agents | 5/04 |
| 7,332,645
| IL-21 Critically Regulates Immunoglobulin Production | 5/04 | E-002-2002
|
| Materials and Methods for Inhibiting Wip1 | 5/04 | E-321-2002
|
| BASE, a New Cancer Gene, and Uses Thereof | 5/04 | E-321-2000
|
| Novel Antisense Oligonucleotides Targeting Folate Receptor Alpha | 5/04 | E-040-2004
|
| Methods for Producing Biliverdin | 4/04 | E-048-2004 E-048-2004 E-048-2004
|
| Construction of a Recombinant Mammalian Expression System for the Production of Human TGF-beta 1 and Members of TGF-beta Superfamily Cytokines | 4/04 | E-061-2003
|
| Long Term Retrievable Venous Filter | 4/04 | E-073-2004
|
| Reduction of HIV-1 Replication by a Mutant Apolipoprotein B mRNA Editing Enzyme-Catalytic Polypeptide-like 3G (APOBEC3G) | 4/04 | E-196-2002
|
| Bromotyrosine-Derived Inhibitors of Mycothiol-S-Conjugate Amidase | 4/04 | E-008-2004
|
| Therapeutic Administration of the Scrambled Anti-Angiogenic Peptide C16Y | 4/04 |
| 7,052,904
| Hybrid Adeno-Retroviral Vector for the Transformation of Cells (E-258-1998) | 4/04 | E-326-2002
|
| Triplex Hairpin Ribozyme | 4/04 | E-069-2004
|
| Formylpeptide Receptor (FPR) as a Target for Anti-Malignant Glioma Therapy | 4/04 | E-142-2002
|
| Reagents to Produce Purified Human 14-3-3 Zeta and 14-3-3 Epsilon as Glutathione-S-Transferase Fusion Protein | 4/04 | E-133-2004
|
| Carbohydrate-Encapsulated Quantum Dots For Cell-Specific Biological Imaging | 4/04 |
| 6,676,657
| Endoluminal Radiofrequency Cauterization System | 4/04 | E-068-2004
|
| MVL, an Antiviral Protein from a Cyanobacterium | 3/04 | E-008-1996
|
| C-C Chemokines That Inhibit Retrovirus Infection | 3/04 | E-125-2001
|
| Novel Spore Wall Proteins and Genes From Microsporidia | 3/04 | E-231-2002
|
| Deazaflavin Compounds and Methods of Use Thereof | 3/04 | E-218-2003 E-218-2003
|
| Method and Apparatus for Bioweapon Decontamination | 3/04 | E-146-1999 E-163-1993 E-135-1989 E-216-2000
|
| BL22, An Immunotoxin That Shows Efficacy in Clinical Trials in Treating Patients with Chemotherapy-Resistant Hairy Cell Leukemia, and Ha22, a Newly Engineered Immunotoxin, Which Shows Improved Cytotoxic Activity Over BL22 | 3/04 | E-028-2004 E-028-2004 E-028-2004
|
| A Novel Interferon-Gamma-Inducible Secretoglobin | 3/04 | E-146-1999 E-135-1989
|
| LMB-2, An Immunotoxin That Shows Efficacy in Phase I Clinical Trials in Treating Patients with Chemotherapy-Resistant Hairy Cell Leukemia and Other Hematologic Malignancies | 3/04 | E-277-2003
|
| Stimulation or Inhibition of Gamma Delta T-Cells to Promote or Inhibit Bone Growth | 3/04 | E-181-2002
|
| Methods and Devices for Intramuscular Stimulation in Dysphonia | 3/04 |
| 6,699,842
| Dominant Negative Deletion Mutants Of C-Jun And Their Use In The Prevention And Treatment Of Cancer | 2/04 |
| 5,935,575
| Interleukin-4 Stimulated T-Lymphocyte Cell Death for the Treatment of Autoimmune Diseases, Allergic Disorders and Graft Rejection | 2/04 | E-173-2003
|
| Interference with c-maf Function in Multiple Myeloma Retards Tumor Adherence and Progression and Decreases Expression of Integrin beta7, C-C Chemokine Receptor 1, and Cyclin D2 | 2/04 | E-244-2002
|
| Glioma-Selective Polypeptides, Alone or Coupled to a Therapeutic/Diagnostic Agent, Compositions Comprising Same, and Uses Thereof | 2/04 | E-286-2002 E-286-2002 E-286-2002
|
| Aerosolized Capreomycin for Inhibition of Pulmonary Tuberculosis | 2/04 | E-250-2002 E-250-2002
|
| Safer Attenuated Virus Vaccines with Missing or Diminished Latency of Infection (E-250-2002) | 2/04 | E-037-2001
|
| Use of IL-13 Inhibitors to Prevent Tumor Recurrence | 2/04 | E-091-2003
|
| Methods for the Treatment of Parkinson's Disease and Other alpha-synucleinopathies | 2/04 |
| 5,460,941 5,510,473 5,707,811 | Homologous DNA Recombination | 2/04 |
| 6,083,503 5,989,546
| Interleukin-2 Stimulated T-Lymphocyte Cell Death for the Treatment of Autoimmune Diseases, Allergic Disorders and Graft Rejection | 1/04 | E-084-1999
|
| Methods for Inhibiting Chaperone Proteins | 1/04 |
| 6,632,808
| Inhibitors of Amyloid Formation | 1/04 |
| 5,276,059
| Inhibition of Diseases Associated with Amyloid Formation | 1/04 |
| 6,211,149 6,355,610
| Inhibitors of Formation of Protease Resistant Prion Protein | 1/04 | E-324-2003
|
| Streptococcus Lipoprotein Antigens | 12/03 | E-022-2003
|
| Discovery of Novel Inhibitors of HIV-1 Integrase and/or RNase H That Can Be Used for the Treatment of Retroviral Infection Including AIDS | 12/03 | E-189-2003
|
| Thalidomide Analogs | 12/03 |
| 6,596,690
| Vasostatin as Marrow Protectant | 12/03 | E-024-2002
|
| Methods and Compositions of Defensin-Antigen Fusion Proteins and Chemokine-Antigen Fusion Proteins as Vaccines for Tumors and Viral Infection | 12/03 | E-276-2001
|
| Improved Endogenous Opioid Anti-Nociception with Reduced Neurodegeneration, Hyperalgesia, Allodynia and Tolerance | 12/03 | E-109-2000
|
| Pain Control by the Selective Local Ablation of Nociceptive Neurons | 12/03 | E-081-2002
|
| A Mouse Model for Human Osteoarthritis | 12/03 | E-276-2003
|
| HIV-Dependent Expression Vector | 12/03 | E-019-2004
|
| Construction of Replication-Competent Chimeric Simian Immunodeficiency Virus (SIV) Human Immunodeficiency Virus Type 1 (HIV-1) Viruses that Replicate Using HIV-1 Reverse Transcriptase and Integrase (IN): A Model System for Development and Testing of Antiviral Agents for the Treatment of HIV-1 Infection | 12/03 | E-297-2002
|
| Methods of Preparing Lymphocytes that Express Interleukin-2 and Their Use in the Treatment of Cancer | 12/03 | E-227-2002
|
| Targeting of the Hepatitis A Cellular Receptor to Treat Renal Cancer | 12/03 | E-191-2001
|
| gp64 Pseudotyped Vectors and Uses Thereof | 11/03 | E-337-2001
|
| Efficient Inhibition of HIV-1 Viral Entry Through a Novel Fusion Protein Including CD4 | 11/03 | E-253-2003
|
| Cytotoxic Indeno- and Isoindenoisoquinoline Compounds | 11/03 | E-224-2003
|
| Inhibition of Retrovirus Gene Expression by PSF | 11/03 | E-072-2001
|
| Identification of New Small RNAs and ORFs | 11/03 |
| 4,810,777 5,567,681 5,643,876 | Antimicrobial Magainin Peptides | 11/03 |
| 6,875,855
| Molecular Diagnosis of Disseminated Candida albicans Infection Using Hemoglobin-Response Gene | 11/03 | E-169-2003
|
| Geldanamycin Derivatives with Methyl Substituted Hydrogen Atom at the N22 Position as Anti-Cancer Agents | 11/03 | E-064-2003
|
| Degradation and Transcriptional Inhibition of HIF-2alpha Protein by 17-AAG | 11/03 | E-038-2003
|
| High Efficiency Single Stranded Homologous Recombination in Host Cells Deficient for Mismatch Repair | 11/03 | E-253-2002
|
| Compositions and Methods for Detecting Abnormal Cell Proliferation | 11/03 | E-008-2001
|
| Compositions and Methods for Enhancing Differential Gene Expression | 11/03 | E-537-1983 E-970-1997
|
| Leukoregulin, An Antitumor Lymphokine, and Its Therapeutic Uses | 11/03 |
| 5,629,454 5,869,666 5,840,728 | Conformationally Locked Nucleoside Analogues
and
Conformationally Locked Nucleoside Analogs As Antiherpetic Agents | 11/03 | E-090-1994 E-090-1994 E-200-1994 E-200-1994 E-200-1994 E-200-1994 E-201-1994 E-201-1994 E-201-1994 E-201-1994
|
| Novel Antimalarial Compounds, Methods of Synthesis Thereof, Pharmaceutical Compositions Comprising Same, and Methods of Using Same for Treatment and Prevention of Malaria | 11/03 | E-055-2002
|
| Novel Stable Anti-CD22 Antibodies | 11/03 | E-342-2002 E-342-2002
|
| beta-Defensins as Activators of Dendritic Cells and Vaccine Carrier | 11/03 | E-285-2002
|
| Lutozmyia longipalpis Polypeptides and Methods of Use | 11/03 | E-083-2003
|
| Intracellular Trapping of Radionuclides by Enzyme-Mediated Reduction | 11/03 | E-223-2002
|
| Factors That Bind Intestinal Toxins | 10/03 | E-294-2002
|
| A New Target for Angiogenesis and Anti-Angiogenesis Therapy | 10/03 | E-019-2003 E-001-2003 E-001-2003
|
| Methods and Materials for Controlling Stem Cell and Cancer Cell Proliferation and Differentiation | 9/03 | E-145-2002
|
| Sigma-2 Receptor Agonists Inhibit HIV Infection and Replication in Lymphocytes | 9/03 | E-016-2000 E-016-2000 E-016-2000
|
| Cloning and Characterization of VIAF in Several Organisms | 9/03 |
| 5,622,861
| Hepatitis A Virus Receptor And Methods Of Use | 9/03 | E-224-2002
|
| Novel Anti-Tumor and Anti-Fungal Compounds Isolated from Plants of the Genus Aniba | 8/03 |
| 7,364,719
| Vasopressor Peptide Derived From Adrenomedullin and Methods of Its Use | 8/03 | E-063-2003
|
| Rapamycin Resistant T Cells and Therapeutic Uses Thereof | 8/03 | E-143-2002 E-143-2002
|
| Method for the Treatment of Multiple Sclerosis | 8/03 | E-301-2002
|
| Cycloxygenase Inhibition with Nitroxyl | 8/03 | E-329-2001
|
| Licensing/CRADA Opportunity to Develop Therapeutic Uses for the Newly Identified Cardiac Precursor Cells Named "SPOC" Cells | 8/03 | E-327-2002
|
| Inhibition of HIV-1 Replication by the Ribonuclease, Recombinant Angiogenin | 8/03 | E-273-2002
|
| Nitroxyl Progenitors in the Treatment of Heart Failure | 8/03 | E-225-2003
|
| Protection Against Vertical Transmission of Pathogenic Infections | 8/03 | E-329-2001
|
| Stem Cells that Transform to Beating Cardiomyocytes | 7/03 | E-251-2002 E-251-2002
|
| Structurally Rigid Dopamine D3 Receptor Selective Ligands as Cocaine and Methamphetamine Abuse Therapeutics | 7/03 | E-049-2001
|
| Long-Acting Insulinotropic Peptides and Uses Thereof | 7/03 | E-281-2001
|
| Oral Treatment of Hemophilia | 7/03 | E-190-2000 E-190-2000
|
| Methods and Compositions for Inhibiting HIV-Coreceptor Interactions | 7/03 | E-173-2001
|
| HTLV-1 p30II and p12I Proteins as Therapeutic Targets in HTLV-1 Infected Individuals | 6/03 |
| 6,664,263 6,541,483
| Imidazoacridones with Anti-Tumor Activity | 6/03 | E-113-2002
|
| Method for Preparing 17alpha-acetoxy-11beta-(4,N,N-dimethylaminophenyl)-19-norpregna-4,9-diene-3,20-dione, Intermediates Thereof, and Methods for the Preparation of Such Intermediates | 6/03 |
| 7,329,502
| Zap70 Protein Expression as a Marker for Chronic Lymphocytic Leukemia (CLL) | 6/03 | E-304-2000
|
| ABCA13 Nucleic Acids and Proteins, and Uses Thereof | 5/03 | E-097-2003
|
| Triggering Receptors Expressed in Myeloid Cells (TREM) Like Transcript (TLT-1), A Novel Inhibitory Receptor of Platelets and Uses Therefore | 5/03 | E-240-2002
|
| HTLV-1 Cell Binding and Inhibition | 5/03 | E-175-2002 E-076-2003 E-175-2002
|
| Method of Treating Ischemia/Reperfusion Injury with Nitroxyl Anion Donors | 5/03 |
| 7,087,589
| Methanocarba Cycloalkyl Nucleoside Analogues | 5/03 | E-256-2002
|
| 17-AAG Treatment of Diseases Sensitive to c-KIT Down Regulation | 5/03 |
| 6,673,338 6,949,530
| Preparation and Medical Uses of Novel Nitric Oxide Releasing Imidates, Amidines Derived Therefrom, and Enamines | 4/03 | E-003-2003
|
| Amplification and Overexpression of Septin9 MLL Septin-Like Fusion (MSF) and Methods Related Thereto | 4/03 | E-278-98/1
|
| Benzoylalkylindolepyridinium Compounds and Pharmaceutical Compositions Comprising Such Compounds | 4/03 | E-017-2002
|
| Scytovirins and Related Conjugates, Antibodies, Compositions, Nucleic Acids, Vectors, Host Cells, Methods of Production and Methods of Using Scytovirin | 4/03 | E-191-2002
|
| Chondropsin-Class Antitumor V-ATPase Inhibitor Compounds, Compositions and Methods of Use Thereof | 4/03 | 60/447,497
|
| Method and Materials for Promoting Migration of T-Cells to the Vasculature of a Tumor | 4/03 | E-219-2002 E-219-2002 E-219-2002
|
| Methods of Inhibiting Metastasis or Growth of a Tumor Cell | 4/03 | E-060-2000 E-060-2000
|
| sFRP and Peptide Motifs That Interact with sFRP and Methods of Their Use | 4/03 |
| 7,081,452 7,163,935
| Scorpionate-Like Pendant Macrocyclic Ligands, Complexes and Compositions Thereof, and Methods of Using Same | 4/03 | 08/933,003 09/555,229
|
| Spontaneous Breathing Apparatus and Method | 3/03 | E-261-2000
|
| Optimization of Cardiac Contraction by Novel Human Kinase Mediated Differential Phosphorylation of Myosin | 3/03 | E-138-2001
|
| Use of Semenogelin in the Diagnosis, Prognosis, and Treatment of Cancer | 3/03 |
| 5,844,075 6,537,560
| gp100 Cancer Antigens | 3/03 | E-189-2002
|
| Novel Cyclic Polyamines That Release Nitric Oxide in a Biphasic Manner | 3/03 | E-176-2002
|
| Modified Oligonucleotides and Methods of Use Thereof | 3/03 | E-052-2002 E-052-2002
|
| Tumor Suppressor Gene Polypeptides and Related Nucleic Acids, Host Cells, Compositions, and Methods of Use in Inhibition of Cell Growth, Modulation of Gene Expression, and Enhancement of Immune-Response Inducing Effect of a Vaccine | 3/03 |
| 6,368,828
| Attenuated and Dominant Negative Variant cDNAs of STAT6: STAT6b and STAT6c | 3/03 | E-056-2002
|
| Grafting of a Murine Antibody Onto a Human Framework | 2/03 | E-008-2003
|
| Scavenger Receptor BI Targeting for the Treatment of Infection, Sepsis and Inflammation | 2/03 | E-259-2002
|
| Compositions and Methods for Inhibiting Group B Streptococcal-Induced Pulmonary Hypertension in Neonates | 1/03 |
| 6,808,877
| Ligands for FPR Class Receptors that Induce a Host Immune Response to a Pathogen or Inhibit HIV Infection | 1/03 | E-239-02/0
|
| Minimally Immunogenic Variant of Humanized COL-1 Antibody Against Carcinoembryonic Antigen (CEA) | 1/03 | E-144-02/0 E-144-02/1
|
| Novel Broadly Cross-Reactive HIV Neutralizing Human Monoclonal Antibodies Selected from Fab Phage Display Libraries Using a Novel Strategy Based on Alternative Antigen Panning
and
Novel Broadly Cross-Reactive HIV-1 Neutralizing Human Single-Chain Antibodies Derived from X5 by DNA Shuffling and Alternating Antigen Panning
| 12/02 | E-235-2000
|
| Improving Chemotherapy by Increased Killing of Tumor Cells and Protection of Normal Cells Through p38 Kinase Inhibition | 12/02 | E-090-2002
|
| Assays for Assembly of Ebola Virus Pseudoparticles Relevant to Antiviral Therapy and Vaccines | 12/02 | E-238-2001
|
| A Metastasis Suppressor Gene on Human Chromosome 8 and Its Use in the Diagnosis, Prognosis, and Treatment of Cancer | 12/02 | E-013-2002
|
| Humanized Anti-TAG 72 CC49 for Diagnosis and Therapy of Human Carcinomas | 12/02 | E-156-1999
|
| Pyrimidine Phosphorylase as a Target for Imaging and Therapy | 11/02 | E-296-2001
|
| Alleviating Symptoms of Th2-Like Cytokine Mediated Disorders by Reducing IL-13 Receptor-Expressing Cells in the Respiratory Tract | 11/02 | E-198-2001
|
| Use of a Histone Deacetylase Inhibitor to Increase the Entry of an Adenoviral Agent into a Cell | 11/02 | E-216-00/2
|
| PEGylation of Linkers Improves Antitumor Activity and Reduces Toxicity of Immunoconjugates | 11/02 | E-080-2002
|
| Modified Defensins and Their Use | 11/02 | E-292-2001
|
| Use of Mx GTPases in the Prognosis and Treatment of Cancer | 11/02 | E-005-2002
|
| New Gene Expressed in Prostate Cancer and Methods of Use | 11/02 | E-196-2001
|
| Use of Interferon-Inducible 2',5'-Oligoadenylate-Dependent RNase in the Diagnosis, Prognosis, and Treatment of Prostate Cancer | 11/02 |
| 5,359,078 5,482,954 5,498,620 | Signal Transduction Inhibitor Compounds in Clinical Trials as Cancer Therapeutics | 11/02 | E-263-2001
|
| Bone-Forming Composition, Methods for Making and Methods of Use | 11/02 | E-317-2001
|
| Discovery of Novel Inhibitors of HIV-1 Integrase That Can Be Used for the Treatment of Retroviral Infection Including AIDS | 10/02 | E-356-2001
|
| Four Chimpanzee Monoclonal Antibodies that Neutralize Hepatitis A Virus | 10/02 | E-039-99/0 E-039-99/2
|
| A Novel Chimeric Protein For Prevention And Treatment Of HIV Infection | 9/02 | E-300-2001
|
| New Tumor Suppressor Gene, p28ING5 | 9/02 | E-048-2002
|
| Antiproliferative Actions of Human IGF Binding Protein-3 Mutants That Do Not Bind IGF-I or IGF-II | 8/02 | E-096-02/0
|
| An Obligate Domain-Swapped Dimer of Cyanovirin with Enhanced Anti-Viral Activity | 8/02 | E-321-2001
|
| Methods and Compositions for Antagonizing Septic Shock | 8/02 |
| 5,942,230 6,197,528
| Retinoids Can Increase the Potency of Anti-Cancer Immunotoxins | 8/02 | E-247-2001
|
| Methods of Diagnosing and Treating Schizophrenia | 8/02 | E-165-2001
|
| Maxp1, A New Tumor Suppressor Regulated by Ras | 8/02 | E-053-02/0
|
| Methods and Compositions for the Promotion of Hair Growth Utilizing Actin-Binding Peptides | 7/02 | E-129-2001
|
| Mutated Anti-CD22 Antibodies with Increased Affinity to CD22-Expressing Leukemia Cells | 7/02 | E-137-2002
|
| Methods for Treating Cancer in Humans Using IL-21 | 7/02 |
| 6,756,399
| Use of Lipoxygenase Inhibitors and PPAR Ligands as Anti-Cancer Therapeutic and Intervention Agents | 5/02 | E-344-01/0
|
| The Ovachip: A Clinically Useful cDNA Array for Differential Diagnosis of Ovarian Cancer | 5/02 | E-206-2000 E-206-2000
|
| Enhanced Distribution of Therapeutic Agents After Local Delivery | 5/02 | E-113-1999
|
| Sol Fusin: Use of GP64-6HIS to Catalyze Membrane Fusion | 5/02 | E-225-2001
|
| MRP8, A Member of the ABC Transporter Superfamily Highly Expressed in Breast Cancer, and Uses Thereof | 5/02 | E-151-01/0
|
| Method of Promoting Engraftment of a Donor Transplant in a Recipient Host | 5/02 | E-176-01/0
|
| Magnetic Labeling of Cells Using Transfection Agents | 5/02 | E-284-01/0
|
| Specific Inhibition of Gene Expression by Small Double Stranded RNAs | 4/02 | E-174-2000
|
| Effect of COMT Genotype on Frontal Lobe Function | 4/02 | E-051-02/1
|
| Methods for Using Modulators of Extracellular Adenosine or an Adenosine Receptor to Enhance Immune Response and Inflammation | 4/02 | E-323-2000
|
| Activated Dual Specificity Lymphocytes and Their Methods of Use | 4/02 | E-017-00/0
|
| Compositions and Methods for the Diminution or Elimination of Various Cancers | 4/02 | E-099-01/0
|
| Mitochondrial Topoisomerase I | 3/02 | E-253-2000
|
| Artificial Chromosomes That Can Shuttle Between Bacteria, Yeast, and Mammalian Cells | 3/02 | E-079-01/0
|
| Treatment of Pain Based on Parathyroid Hormone-2 (PTH2) Receptors | 3/02 | E-328-2001
|
| Use of CpG Oligodeoxynucleotides to Encourage Angiogenesis | 3/02 | E-360-2001
|
| Generation and Use of Tc1 and Tc2 Cells | 2/02 | E-242-01/0
|
| Strategies to Destabilize the Active HIV-1 Protease Dimer Resulting in Stable Monomer Formation | 2/02 | E-114-01/0
|
| Methods of Generating Human CD4+ Th2 Cells | 2/02 | E-059-2001 E-059-2001
|
| Transforming Growth Factor-Beta (TGF-Beta) Antagonist Selectively Neutralizes "Pathological" TGF-Beta | 2/02 | E-335-01/0
|
| Methods of Generating Human CD4+ Th1 Cells | 2/02 | E-130-01/0
|
| Novel Broadly Reactive HIV-Neutralizing Human Monoclonal Antibody Against Receptor-Induced Epitope on gp120 | 2/02 | E-143-1999
|
| Novel Anti-Thrombin Peptide from the Salivary Gland of Anopheles albimanus | 2/02 | E-265-98/0 E-265-98/1
|
| Identification of Compounds that Potentiate the Activity of Muscarinic Potassium Channels | 2/02 | E-122-2001
|
| Anti-Arthropod Vector Vaccines, Methods of Selecting, and Uses Thereof | 2/02 | E-218-01/0
|
| Identification of DNA Sequence Motifs that Suppress the Immune Response to CpG DNA | 2/02 | E-215-01/0
|
| Use of Sterically Stabilized Cationic Liposomes to Efficiently Deliver CpG Oligonucleotides in vivo | 2/02 | E-214-01/0
|
| Novel Method for Rapidly Generating Mature Dendritic Cells from Peripheral Blood Monocytes and Myeloid Precursors | 2/02 | E-282-01/0
|
| N-Formyl Peptide Receptor Mediation of Platelet Chemotaxis Toward Injured Cells and Activation of Immune Response | 2/02 | E-339-01/0
|
| Filtration of Red Blood Cells | 1/02 | E-172-1999
|
| Peptides that Stabilize Protein Antigens and Enhance Presentation to CD8+ T Cells | 1/02 | E-077-00/0 E-077-00/1
|
| Combined Inhibition of Phosphodiesterase-4 (PDE-4) and Phosphodiesterase-3 (PDE-3) as a Therapy for Th1 Mediated Autoimmune Diseases | 1/02 | E-002-01/0
|
| Tumor Antigen Homologous to Poly(A) Polymerase | 1/02 | E-086-2001 E-086-2001
|
| Novel Peptides to a Melanoma Antigen and Their Use in Diagnostic and Therapeutic Methods | 1/02 | E-295-1999
|
| Gene Involved in Dietary Sterol Absorption and Excretion and Uses Therefor | 1/02 | E-286-2000
|
| Histone Deacetylase Inhibitors in Diagnosis and Treatment of Thyroid Neoplasms | 1/02 | E-161-2000
|
| XAGE-1, A Gene Expressed in Multiple Cancers and Uses Thereof | 1/02 | E-311-2000
|
| Thymidylate Synthase Peptides that Bind to Thymidylate Synthase Messenger RNA | 1/02 | E-126-01/0
|
| Human Papilloma Virus Immunoreactive Peptides | 1/02 | E-089-2001
|
| Suppression of CCR5- but not CXCR4-Tropic HIV-1 Replication in Lymphoid Tissue by Human Herpes Virus 6 | 1/02 |
| 6,673,905 7,211,445
| A Method for Bioconjugation Using Diels-Alder Cycloaddition | 1/02 | E-285-2000
|
| LL-37 is an Immunostimulant | 12/01 | E-167-1999
|
| Utilization of FPRL1 as a Functional Receptor by Serum Amyloid A (SAA) | 12/01 | E-209-01/0
|
| Neurotrophic Components of the ADNF I Complex | 12/01 | E-209-2001 E-209-2001 E-209-2001
|
| Neurotrophic Components of the ADNF I Complex
| 11/01 |
| 5,254,539 5,616,566 5,026,687 | Method of Treating HIV with 2',3'-Dideoxyinosine (ddI; didanosine) | 11/01 | E-278-2000
|
| Differentiation of Stem Cells to Pancreatic Endocrine Cells | 11/01 | E-088-01/0
|
| Diacylglycerol Compounds Useful as Protein Kinase C Activators and Apoptosis Inducers | 11/01 | E-108-01/0
|
| Side Exit Guiding Catheter for Percutaneous Endomyocardial Injection | 10/01 | E-172-2000
|
| Development of a Single Vector Containing cre Recombinase and Two Functional lox Sites: Active cre Produced in Eukaryotic but not Prokaryotic Systems | 10/01 | E-296-2000
|
| Intercellular Delivery of a Herpes Simplex Virus VP22 Fusion Protein from Cells Infected with Lentiviral Vectors | 9/01 | E-067-2001
|
| Secretion of Native Recombinant Lysosomal Enzymes by Liver | 9/01 | E-179-01/0
|
| Identification of a Cell-surface Receptor for Papillomaviruses | 9/01 | E-237-2001
|
| Batrachotoxins as Unique Activators of Sodium Channels | 9/01 | E-033-01/0
|
| New Isoform of Tyrosinase-Related Protein (TRP-2) that Contains an HLA-A2 Restricted Epitope | 9/01 | E-141-2000
|
| Agents Useful for Reducing Amyloid Precursor Protein and Treating Dementia and Methods of Use Thereof | 9/01 | E-175-2001
|
| Methods and Structures for Microengineering Neocartilage Scaffolds | 8/01 | 60/229,842
|
| Sensitization of Cancer Cells to Immunoconjugate-Induced Cell Death by Transfection with Interleukin-13 Receptor Alpha-Chain | 8/01 | E-193-01/0
|
| Single-Chain Antibody Fragment Protein Binding to HIV-1 Integrase | 8/01 | 60/290,722
|
| Modified Leptin | 08/01 | E-105-00/0
|
| Method to Fabricate Continuous Lengths of Helical Coiled Shape Memory Wire | 08/01 | E-123-00/0
|
| Method of Treating Cutaneous T-Cell Lymphoma by Administering a Histone Deacetylase Inhibitor | 8/01 | E-264-2001
|
| A Mouse Model of von Hippel-Lindau Disease | 8/01 | E-243-2001
|
| A Mouse Model of Multiple Endocrine Neoplasia, Type I | 7/01 | E-074-99/7
|
| Glycosylation-resistant Cyanovirins and Related Conjugates, Compositions, Nucleic Acids, Vectors, Host Cells, Methods of Production and Methods of Using Nonglycosylated Cyanovirins | 6/01 | E-053-2001
|
| PRAC & PRAC-Y: Small Nuclear Proteins Found in Prostate and Colon Cancer, and Uses Thereof | 6/01 | E-231-00/0
|
| Virus-Like Particles as Unlinked Adjuvants | 6/01 | E-249-2000
|
| 5-Substituted Derivatives of Conformationally Locked Nucleoside Analogues | 5/01 | E-110-01/0
|
| A Plasmid for Expression of a More Soluble Form of HIV Integrase Protein in E. coli | 5/01 |
| 6,713,081
| Ocular Therapeutic Agent Delivery Devices And Methods | 5/01 | E-222-2000
|
| Novel Inhibitors of p53 for Treatment of Neurodegenerative Disorders, Myocardial Infarction and Other Tissue Insults | 5/01 |
| 5,693,779
| Production and Use of Anti-Dorsalizing Morphogenetic Protein | 4/01 |
| 5,861,158
| Immunization from an Immunized Allogeneic Bone Marrow Donor
| 4/01 |
| 7,351,580
| Use of Endogenous Vertebrate Phytase to Increase Capacity To Utilize Phytic Acid in Livestock Feed | 4/01 |
| 6,949,624
| Cloning of the Human Nuclear Receptor Co-Repressor Gene | 4/01 | E-276-00/0
|
| A Method of Inhibiting Viral Replication Targeting the Nucleocapsid Protein | 4/01 | E-237-1999
|
| Methods for Preventing Strokes by Inducing Tolerance to E-selectin | 4/01 |
| 7,442,212
| Decoding Algorithm for Neuronal Responses | 4/01 | E-188-00/0
|
| Method of Preparing a Production Intermediate for HIV Protease Inhibitors | 4/01 |
| 6,756,215
| Biologically Active FLAG-Epitope-Tagged Transforming Growth Factor Beta (TGF-beta) Protein | 3/01 | E-144-00/0
|
| GHEP, A Gene Highly Expressed in Normal and Neoplastic Prostate, and Uses Therefor | 2/01 |
| 6,974,698
| Methods for Delivering Biologically Active Molecules into Cells | 2/01 | E-291-99/0
|
| Efficient Generation of Midbrain Neurons from Mouse Embryonic Stem Cells | 2/01 | E-186-00/0
|
| Radio Frequency Probes for Tissue Treatment and Methods of Use | 2/01 | E-001-2001 E-001-2001
|
| Coupled Calcium/Citrate Delivery System and Method for Apheresis Devices | 2/01 | E-015-2000
|
| Antiprogestins with Partial Agonist Activity | 2/01 | E-237-2000
|
| RASS1: A Novel Tumor Suppressor Gene Activated by Ras to Promote Apoptosis | 2/01 | E-165-1999
|
| Potentiation of Antineoplastic Agents Using Sigma 2 Ligands | 2/01 |
| 6,280,734
| Simian-Human HAV Chimeras Encoding a Hepatitis A Virus Having a Chimeric 2C Protein | 02/01 | E-288-00/0
|
| The ImmunoChip | 1/01 | E-047-01/0
|
| Ribonuclease H1 - A Protein Expressed in Escherichia coli from a Cloned Human RNase H1 cDNA | 12/00 | E-123-1999
|
| PTH2 and PTH1 Receptor Ligands | 12/00 | E-066-2000
|
| Method of Regulating Interleukin-12 (IL-12) Production by Administering CCR5 Agonists and Antagonists | 12/00 | E-281-2000
|
| A Mouse Model of UV-Inducible Cutaneous Malignant Melanoma | 12/00 | E-259-00/0
|
| Protein Kinase A and the Carney Complex | 12/00 | E-243-00/0
|
| Gamma-Glutamyl Transpeptidase Inhibitors: Novel Chemotherapeutic Agents | 12/00 |
| 6,521,635
| Inhibition of MXR Transport by Acridine Derivatives | 12/00 | E-272-2000
|
| Human Erythropoietin Receptor Transgenic Mice | 12/00 | E-223-00/0
|
| Transcranial Magnetic Stimulation Coil for Specific Non-Invasive Deep Brain Stimulation | 12/00 | E-170-2000
|
| NAG-1: A Non-Steroidal Anti-Inflammatory Drug Related Gene Which Has Anti-Tumorigenic Properties | 12/00 | 60/209,067
|
| Peroxynitrite Generators, Compositions Comprising Same, and Methods for Treating Biological Disorders Using Same | 12/00 | E-129-2000
|
| Gadd45a-Null Mice (45C Clone) and Cells Derived from Them | 12/00 |
| 7,101,541
| Utilization of Non-Viral Sequences for Minus-Strand DNA Transfer and Gene Reconstitution | 12/00 | E-161-2000
|
| Discovery of Gene Expressed in Many Cancers and Only Normal Testis | 12/00 | E-192-2000
|
| HCDS1 Kinase Activates Breast Tumor Suppressor BRCA1 and Promotes DNA Damage Repair | 12/00 | E-194-2000
|
| Methods and Compositions of Viral Chemokine-Antigen Fusion Proteins as Vaccines for Tumors and AIDS | 12/00 | E-196-2000
|
| Antitumor Immunity Elicited by Defensin-Tumor Antigen Fusions | 12/00 | E-207-2000
|
| Ixodes Salivary Anticomplement Protein | 12/00 |
| 7,078,508
| Ixodes scapularis Tissue Factor Pathway Inhibitor | 12/00 | E-014-2000
|
| Secreted Frizzled Related Protein, sFRP, Fragments and Methods of Use Thereof | 12/00 | E-056-00/0
|
| T-Cell Epitope of MAGE-12 and Related Nucleic Acids, Vectors, Cells, Compositions, and Methods of Inducing an Immune Response to Cancer | 12/00 | E-090-2000 E-227-2000 E-090-2000
|
| Novel MHC Class II Restricted T Cell Epitopes from the Cancer Antigen, NY-ESO-1
and
MHC Class II Restricted CD4+ T Cell Epitopes From NY-ESO-1 Presented by DP
| 12/00 | E-126-2000
|
| A Method for Bioconjugation Using Diels-Alder Cycloaddition
| 11/00 |
| 7,144,734
| Enhanced Homologous Recombination Mediated by Lambda Recombination Proteins
| 9/00 | E-061-1999
|
| Polypeptides Comprising IL-6 Ligand Binding Receptor Domains and Related Nucleic Acids, Antibodies, Compositions and Methods
| 9/00 | E-093-2000
|
| Method of Diagnosing Multidrug Resistant Tuberculosis | 9/00 |
| 6,737,511
| Receptor-Mediated Uptake of an Extracellular Bcl-XL Fusion Protein Inhibits Apoptosis
| 8/00 | E-149-1999
|
| Ichthyosiform Skin Diseases
| 8/00 |
| 6,448,245
| HIV Protease Inhibitors, Ritonavir and Saquinavir are Potent Inhibitors of Calcium Activated Neutral Peptidases, Calpains | 8/00 | E-286-1999
|
| Constitutively Open Voltage-Gated K+ Channels and Methods for Discovering Modulators Thereof
| 8/00 | E-277-98/0
|
| Delivery of Proteins Across Polar Epithelial Cell Layers | 7/00 | E-068-2000
|
| Molecules That Influence Pathogen Resistance | 7/00 |
| 7,132,392
| Inhibition of Cell Motility | 7/00 | E-245-99/0
|
| Polypeptides that Bind HIV gp120 and Related Nucleic Acids, Antibodies, Compositions, and Methods of Use
| 7/00 | E-087-2000
|
| Establishment of Cellular Manipulations Which Enhance Oligo-Mediated Gene Targeting
| 7/00 | E-243-1999
|
| Fibroblast Growth Factor-5 (FGF-5) is a Tumor Associated T-cell Antigen for Human Renal Cell Cancer and Other Adenocarcinomas
| 7/00 | E-062-2000
|
| A Novel Pro-Apoptotic Protein, ARTS | 6/00 |
| 6,419,639
| Laparoscopic Sac Holder Assembly | 6/00 | E-072-99/0 E-072-99/1
|
| Transition Metal Complexes of N,N',N''-trialkyl-cis,cis-1,3,5-triaminocyclohexane and Related Compositions and Methods | 6/00 | E-032-99/1
|
| Direct C-14 Oxidation of Opioids | 5/00 |
| 6,881,718
| Novel Disulfide Conjugated Cell Toxins and Methods of Making and Using Them | 4/00 | E-257-1999
|
| Methods and Compositions for Correlating CCR5 Expression with Essential Hypertension | 4/00 |
| 6,855,323
| Identification of the Domain of Plasmodium falciparum Erythrocyte Membrane Protein (PfEMP1) that Mediates Adhesion to Chondroitin Sulfate A | 4/00 |
| 5,489,525
| Monoclonal Antibody Specific to Prostate Cells | 4/00 |
| 6,441,156 6,979,724
| Calcium Channel Compositions and Methods of Use Thereof
| 1/00 |
| 6,743,626
| Artificial Salivary Gland | 10/99 |
| 6,613,764 7,132,420
| Aspartic Protease Inhibitors, Compositions, and Associated Therapeutic Methods | 10/99 |
| 5,728,718 5,925,780 6,066,656 | 2,5-diamino-3,4-disubstituted-1,6-diphenylhexane Isosteres Comprising Benzamide, Sulfonamide and Anthranilamide Subunits and Methods of Using | 9/99 | E-076-1999
|
| Acetylated and Related Analogues of Chicoric Acid as HIV Integrase Inhibitors | 9/99 | 60/108,903
| 9,927,341
| Identification of Globotriaosylceramide as a Promoter of HIV-1 Entry into Cells | 9/99 | 60/141,072
|
| Antiviral Genetic Target Within HIV gag-pol Transframe Region | 9/99 | 60/141,701
|
| Human Monoclonal Antibodies to HIV-1 Envelope Glycoprotein gp120 | 9/99 |
| 6,613,318 7,005,419 7,125,850 | Methods For Identifying Modulators Of GADD45 Polypeptide Activity | 9/99 | E-271-1998
|
| Methods For Treating Tumors Using Anti-Angiogenic Compounds | 9/99 |
| 6,686,333
| Inhibition of HIV Replication Using Soluble Tat Peptide Analogs | 9/99 | 09/313,487
|
| Identification and Use of High Efficacy Vaccine Antigens Which Modulate Antigen Presenting Cells | 9/99 |
| 6,057,346
| Inhibition of Retroviral LTR Promoters by Calcium Response Modifiers | 9/99 |
| 6,316,190
| Oligonucleotides Which Specifically Bind Retroviral Nucleocapsid Proteins | 8/99 |
| 6,323,316 6,608,181 6,831,170 | Fibroblast Growth Factor Receptor Activating Gene 1 (FRAG1), Related Proteins and Methods | 8/99 |
| 7,129,052
| Peptides and Their Utility in Modulation of Behavior of Cells Expressing alpha3beta1 Integrins | 8/99 |
| 4,923,970
| A New Class of Anti-Tumor Agents | 8/99 | 60/094,690
|
| Thymosin Ć4 Promotes Wound Repair | 8/99 |
| 5,857,309 5,888,705
| Methods of Stimulating Proliferation and Differentiation of Human Pancreatic Cells Ex Vivo | 8/99 | E-176-1998
|
| Apoptosis Inducing Agents and Methods | 8/99 |
| 7,226,991
| Phenylalanine Derivatives | 7/99 | E-068-1999
|
| UPA, A Universal Protein Array System For Quantitative Detection Of Protein-Protein, Protein-DNA, Protein-RNA And Protein-Ligand Interactions | 7/99 |
| 6,479,465
| Methods of Treating Colitis Using STAT-4 Antisense Oligonucleotide | 7/99 |
| 6,696,551 6,995,247
| Ac-HEHA and Related Compounds, Methods of Synthesis and Methods of Use | 7/99 | E-121-99/0
|
| Methods For Mitochondrial Gene Therapy
| 7/99 | 09/271,009
|
| Low Level Exposure To Extract Of Neurotoxin For Protection From Brain Injury | 7/99 |
| 5,998,598
| Immunoadhesins and Methods of Production Thereof | 6/99 |
| 5,843,882 6,015,876
| Cyanovirin-Based Topical Microbicides For Prevention Of Sexual Transmission Of HIV | 6/99 |
| 6,677,314 6,677,315 6,753,309 | Nucleosides for Imaging and Treatment Applications | 6/99 |
| 6,596,269
| Virally Mediated Gene Therapy For The Control Of Chronic Or Persistent Pain | 6/99 |
| 6,610,660 6,911,433 7,081,524 | O2-Arylated or O2-Glycosylated 1-Substituted Diazen-1-ium-1,2-diolates and O2-Substituted 1-[(2-Carboxylato)Pyrolidin-1-yl] Diazen-1-ium-1,2-diolates | 6/99 |
| 6,307,090
| Acylated Oligopeptide Derivatives Having Cell Signal Inhibiting Activity | 6/99 |
| 6,238,858
| Transgenomic Viruses
| 6/99 |
| 6,423,696
| Modulation of N-Acetyl-Transferase to Improve Therapy and Prevent Cancer
| 6/99 | 60/119,114
|
| Identification of the Geldanamycins as Inhibitors of the HGF/SF-Met-uPA Proteolytic Network | 6/99 | 60/113,423
|
| Water-Insoluble Drug Delivery System | 6/99 | E-282-1998
|
| Antagonists of the Alpha Epsilon Beta 7 Integrin as Therapeutic Agents for Inflammatory Diseases | 6/99 |
| 5,562,905
| Immunologically Active Peptides From The HIV Envelope Protein Eliciting Both Antibody And T Cell Responses | 6/99 | 60/097,446
| 9,918,674
| Modified HCV Peptide Vaccine | 5/99 |
| 6,221,620
| Monoclonal Antibodies Specific for Human Thymidylate Synthase | 4/99 | E-175-1998
|
| Human Cancer Antigen TRP2 | 4/99 | E-157-94/1
|
| Method and Composition for Detecting Dihydropyrimidine Dehydrogenase Splicing Mutations | 4/99 |
| 5,849,691
| Peptidomimetic Inhibitors of Cathepsin D and Plasmepsins I and II | 4/99 |
| 5,872,210
| Transframe Peptide Inhibitor Of Viral Protease | 3/99 |
| 6,316,423
| Method of Treating Ischemic, Hypoxic, and Anoxic Brain Damage
| 3/99 | E-006-98/0
|
| Methods and Compositions for Reducing Ischemic Injury of the Heart by Administering Adenosine A3 and Adenosine A1 Receptor Agonists | 3/99 | 08/813,787
|
| Methods and Compositions for Protecting Against Cardiac Ischemia by Administering Adenosine A2a Receptor Antagonists | 3/99 |
| 6,485,925
| Anthrax Lethal Factor is a MAPK Kinase Protease
| 3/99 | E-301-1998 E-301-1998 E-301-1998
| 6,630,124 | Combination Therapy With VIP Antagonists | 3/99 |
| 5,645,988
| Method of Identifying and Using Drugs with Selective Effect Against Cancer Cells | 3/99 |
| 6,552,181
| A Basal Cell Carcinoma Tumor Suppressor Gene | 2/99 |
| 6,867,180
| Use Of Calreticulin And Calreticulin Fragments To Inhibit Endothelial Cell Growth And Angiogenesis, And Suppress Tumor Growth | 2/99 | E-130-97/1
|
| Polynucleotide Inhibition Of RNA Destabilization And Sequestration | 2/99 | E-196-1998 E-196-1998
|
| Pressure Mediated Selective Delivery Of Therapeutic Substances
| 2/99 |
| 6,719,978
| Chimeric Virus-Like Particles For The Induction Of Autoantibodies | 2/99 |
| 6,458,590
| Methods and Compositions for Treatment of Restenosis | 2/99 | E-196-1998 E-196-1998 E-196-1998
|
| Pressure Mediated Selective Delivery Of Therapeutic Substances | 2/99 |
| 6,787,356
| Cell Expansion System For Use In Neural Transplantation | 2/99 |
| 5,942,433 6,361,968
| Extension Of A Protein-Protein Interaction Surface To Inactivate The Function Of A Cellular Protein | 1/99 | 09/023,726
| 6,060,458
| Oligodeoxyribonucleotides Comprising O6-Benzylguanine and Their Use | 01/99 | 09/128,450 09/823,494
| 6,211,149
| Inhibitors of Formation of Protease Resistant Prion Protein | 1/99 |
| 5,474,935
| Adeno-Associated Virus (AAV)-Based Eucaryotic Vectors | 1/99 | 60/076,330 09/623,000
| 9,904,002
| Disubstituted Lavendustin A Analogs And Pharmaceutical
Compositions Comprising the Analogs
| 1/99 |
| 7,029,899
| Amino-Terminus-Modified Eosinophil-Derived Neurotoxin and Its Selective Toxicity to Kaposi's Sarcoma Cell Line, KS Y-1 | 12/98 |
| 6,492,166
| Use of Constitutive Transport Elements to Control the Host Range of Retroviral Vectors
| 12/98 | 60/096,148
| 9,918,297
| Inhibitors Of Formation Of Transmissible Spongiform Encephalopathy-
Associated Prion Protein By Porphyrins And Phthalocyanines
| 12/98 |
| 6,534,626
| Chemokine Variants And Methods Of Use | 12/98 |
| 6,197,751
| Thymosin alpha 1 Promotes Tissue Repair, Angiogenesis and Cell Migration
| 12/98 |
| 6,326,466
| Double-Stranded RNA Dependent Protein Kinase Derived Peptides To Promote Proliferation Of Cells And Tissues In A Controlled Manner | 12/98 | E-032-96/1
|
| Infectious Papillomavirus Pseudoviral Particles | 12/98 |
| 5,720,892 5,824,520
| Method of Inhibiting the Activity of an Intracellular Constituent | 12/98 | E-066-1996
|
| AAV4 Vector And Uses Thereof | 11/98 |
| 6,562,859
| Ureido Derivatives Of Poly-4-Amino-2-Carboxy-1-Methyl Pyrrole Compounds For Treatment Of Inflammation | 11/98 |
| 4,892,827
| Drug and Method for the Therapeutic Treatment of Primary Brain Tumors (Such As Intracranial Human Glioma, Astrocytomas, Medulloblastomas and Metastatic Tumors to the Central Nervous System) | 10/98 |
| 5,455,251 5,654,432
| Michellamine Antiviral Agents, Compositions, And Treatment Methods | 10/98 |
| 5,552,550 5,763,613
| Monomeric Naphthylisoquinoline Alkaloids And Synthesis Methods Thereof | 10/98 |
| 5,571,919 5,789,594
| Dimeric Naphthylisoquinoline Alkaloids And Synthesis Methods Thereof | 10/98 |
| 5,409,938
| Antimalarial Korupensamines And Pharmaceutical Compositions And Medical Uses Thereof | 10/98 |
| 5,639,761 6,627,641
| Antimalarial Napthylisoquinoline Alkaloids And Pharmaceutical Compositions And Medicinal Uses Thereof | 10/98 |
| 6,365,712 6,846,911
| Methods And Compositions For Inhibiting Inflammation And Angiogenesis | 10/98 |
| 6,068,844
| The Application Of Induction Tolerance By Oral Feeding Of Myelin Basic Protein To The Generation Of Increased Resistance To Stroke | 10/98 |
| 6,140,339 6,331,630
| Monomeric And Dimeric Arylisoquinoline Alkaloids And Derivatives Thereof | 10/98 |
| 5,578,729 5,786,482
| Dimeric Arylisoquinoline Alkaloids And Synthesis Methods Thereof | 10/98 |
| 6,630,507
| Cannabinoids As Neuroprotectants | 9/98 | E-174-1997
|
| Protection Of Tissue From Ischemic Damage | 9/98 |
| 6,747,055
| Water Soluble Drugs and Method of Preparing Same | 9/98 |
| 6,084,063 6,353,097
| Signal Transduction Inhibitors Of Allergic Reactions | 9/98 | 60/076,293 09/643,548
| 9,900,967
| Therapeutic Blockage of ICER Synthesis to Prevent ICER-Mediated Inhibition of Immune Cell Activity | 9/98 | 60/075,994
| 9,904,336
| Inhibition Of HFG/SF Cleavage/Activation By Suramin And Other Related
Small Molecules
| 9/98 |
| 7,105,488
| G-Protein Coupled Receptor Antagonists | 9/98 | 60/076,293 09/643,548
| 9,900,967
| Therapeutic Blockage of ICER Synthesis to Prevent ICER-Mediated Inhibition of Immune Cell Activity | 9/98 | E-166-1998
|
| LIF And Related Cytokines That Operate Through The gp130 Receptor Pathway As A Means To Enhancing Embryo Implantation In Mammals And As An Alternative To Using Estrogen | 9/98 | 60/094,246
|
| Protection Of Neural Cells From Catecholamine-Induced Apoptosis By
Macrophage Migration Inhibitory Factor (MIF)
| 9/98 |
| 6,046,228
| Anti-Viral Pharmaceutical Compositions Containing 1,2-Dithiane Compounds And Methods Of Using Thereof
| 7/98 | E-013-1996
|
| Compound, Composition, and Method for Treating Cancer | 7/98 | E-070-97/0
|
| Cloning Of GMEB 1 And 2: Two Proteins Involved In The Modulation Of Glucocorticoid Regulated Gene Transcription | 5/98 |
| 6,313,090
| Methods For Treating Parasitic Infection Using Thiopeptides | 3/98 | 09/124,955
|
| CC Chemokine Receptor 8 DNA, New Animal Models and Therapeutic Agents for HIV Infection | 3/98 |
| 6,084,099 6,277,980
| Human Papilloma Virus Inhibition By Antisense Oligonucleotides | 03/98 | 09/402,275
|
| STRL33, A Human Fusion Accessory Factor Associated With HIV Infection | 3/98 |
| 6,600,030
| Delayed Progression To AIDS By A Missense Allele Of The CCR2 Gene | 3/98 |
| 6,383,746
| Functional Promoter For CCR5 | 1/98 | E-032-1997
|
| Method Of Promoting Tumor Necrosis Using MIG | 1/98 |
| 5,914,121
| Formation Of Human Bone In Vivo | 12/97 | 60/033,918
| 9,800,784
| Enhanced Suppression Of HIV-1 by the Combination of Cytidine Dideoxynucleoside Analogues And CTP Synthase Inhibitors | 11/97 |
| 6,627,745
| Identification Of The Gene Causing Familial Mediterranean Fever | 11/97 |
| 6,426,070
| Methods For Inactivating Enveloped RNA Virus Particles And Compositions For Use Therewith
| 10/97 |
| 6,562,589 7,232,890
| AIB-1, A Steroid Receptor Co-Activator Amplified In Breast And Ovarian Cancer
| 10/97 |
| 6,861,415
| 21-Substituted Progesterone Derivatives As New Antiprogestational Agents | 10/97 |
| 6,689,560
| raf Protein Kinase Therapeutics | 10/97 |
| 5,514,539 5,871,962 6,572,864 | Diagnostic Reagents And Vaccines For Multiple Genotypes Of Hepatitis C Virus | 10/97 |
| 5,092,885
| Peptides With Laminin Activity | 8/97 | E-011-97/0
|
| Transgenic And Chimeric Viral Delivery Systems | 8/97 |
| 7,358,347
| MEN1, The Gene For Multiple Endocrine Neoplasia Type 1 | 5/97 |
| 6,884,871 6,924,367 7,049,291 | Isolation And Use Of Tissue Growth-Inducing FRZB Protein | 5/97 |
| 5,840,839 6,097,110 5,831,016 | Novel Human Cancer Antigen of Tyrosinase-Related Proteins 1 and 2 and Genes Encoding Same | 5/97 | 08/618,936
|
| Prostate Specific Antigen Oligo-Epitope Peptide | 5/97 |
| 5,449,608
| Parvovirus B19 Receptor And Parvovirus B19 Detection | 5/97 |
| 5,656,737
| Macrophage Migration Inhibitory Factor (MIF) | 05/97 | 60/030,999
| 9,721,723
| Vanilloid Agonists for Desensitization of C-Fiber Sensory Afferent Neurons | 5/97 |
| 6,387,389
| Sustained-Release Derivatives of Hydroxylated Analogs of Substituted 1-
[2[bis(aryl)methoxy]-ethyl] -Piperazines and -Homopiperazines and Their
Use as Noncompetitive Antagonists of Dopamine Reuptake Inhibitors
| 4/97 |
| 5,637,323
| Method Of Mobilizing Pluripotent Hematopoietic Stem Cells And Accelerating Leukocyte Reconstitution With IL-7 | 1/97 |
| 6,780,413
| Immunotoxin (MAB-RICIN) For The Treatment Of Focal Movement Disorders | 1/97 | E-131-2994
|
| Substantially Pure Non-IL-2 T-Cell Growth Factors | 1/97 |
| 6,156,765
| 2,2'-Bipyridyl, a Ferrous Chelator, Prevents Vasospasm in a Primate Model of Subarachnoid Hemorrhage | 1/97 |
| 5,830,755
| T-Cell Receptors And Their Use In Therapeutic And Diagnostic Methods | 1/97 | 08/172,664
| 5,674,492
| Method Of Preventing Or Treating Disease Characterized By Neoplastic Cells Expressing CD40 | 1/97 |
| 6,951,917
| MHC Class II-Restricted Melanoma Antigens And Their Use In Therapeutic Methods | 12/96 |
| 6,391,651 5,989,551
| Materials And Methods For Detection And Treatment Of Insulin Dependent Diabetes | 12/96 |
| 5,792,775
| 4'- And 4',4"-Substituted-3alpha(diphenylmethoxy)tropane Analogs As Cocaine Therapeutics | 12/96 |
| 5,428,154
| Macrocyclic Chelates, and Methods of Use Thereof | 11/96 | 60/023,931 09/242,202
| 9,714,306
| A Novel Vector for Polynucleotide Vaccines | 11/96 | E-088-1996
|
| Point Mutated ras Peptides for the Generation of CD8+ Cytotoxic T Lymphocytes | 11/96 | 09/185,408
|
| Glycoprotein Hormone Superagonists | 11/96 |
| 6,197,578
| Cells Expressing Both Human CD4 And A Human Fusion Accessory Factor Associated With HIV Infection | 10/96 |
| 5,317,009
| Anti-HIV Proteins GAP 31, DAP 30 And DAP 32 And Therapeutic Uses Thereof | 10/96 |
| 5,532,214
| An Anti-HIV Protein, TAP 29, From Trichosanthes, DNA Coding Therefor And Therapeutic Uses Thereof | 10/96 |
| 5,484,889
| Plant Protein Useful For Treating Tumors And HIV Infection | 9/96 | 06/481,934
| 4,565,789
| Cell Matrix Receptor System And Use In Cancer Diagnosis And Management | 8/96 |
| 5,405,782
| A Detection Device and Quantification Method for Therapeutic Agents in Blood | 8/96 |
| 5,677,275 5,877,148
| Treatment Of Cancer With Human Chorionic Gonadotropin | 8/96 |
| 5,571,156
| Method For In Situ Testing Of Integrity Of Electrical Stimulator Leads | 8/96 |
| 5,678,550
| Apparatus And Method For The In-Situ Detection Of Areas Of Cardiac Electrical Activity | 8/96 |
| 5,763,464
| Novel Retroviral Agents Containing Anthranilamide, Substituted Benzamide And Other Subunits, And Methods Of Using Same | 7/96 |
| 5,853,697
| Methods Of Treating Established Colitis Using Antibodies Against IL-12 | 7/96 |
| 5,183,884 5,480,968 5,820,859 | Novel Epidermal Growth Factor Receptor (ErbB-3) And Antibodies | 7/96 |
| 6,319,687
| Pigment Epithelium Derived Factor: Characterization, Genomic Organization and Sequence of PEDF Gene | 7/96 |
| 5,526,395
| System And Method For Simulating A Two-Dimensional Radiation Intensity Distribution Of Photon Or Electron Beams | 7/96 |
| 6,566,098
| Truncated Hepatocyte Growth Factor Variants | 7/96 |
| 5,840,686
| Pigment Epithelium Derived Factor: Characterization of Its Novel Biological Activity and Sequences Encoding and Expressing the Protein | 7/96 |
| 5,578,566
| Peptide Antagonist Of Keratinocyte Growth Factor Activity | 7/96 | 08/004,936 08/858,248 08/858,925 | 5,837,477 5,948,409 5,958,712 | T Cell Receptor Ligands, And Methods For Use | 7/96 |
| 5,219,991 5,527,685
| Macrophage Stimulating Protein | 7/96 | 06/724,897
| 4,707,443
| Soluble Interleukin-2 Receptor As A Disease Indicator And A Method Of Assaying The Same | 7/96 |
| 5,352,772
| 75 Kilodalton Interleukin-2 Receptor Proteins And Their Use | 4/96 | E-131-1991
|
| Adenovirus Mediated Transfer Of Genes To The Gastrointestinal Tract | 4/96 |
| 5,439,899
| Cosalane And Related Compounds Having Activity Against AIDS And AIDS-Related Infections | 4/96 |
| 5,672,593 5,731,301 5,808,038 | Bistriazenes as Chemotherapeutic Agents | 4/96 |
| 5,518,558 5,654,406
| ERBB2 Promoter Binding Protein In Neoplastic Disease | 4/96 |
| 5,716,788 5,763,216
| A Gene Encoding a Human Reduced Folate Carrier (RFC) and Methods for the Treatment of Methotrexate-Resistant, Transport-Deficient Cancer Cells | 4/96 | 08/445,462
|
| Avian Based Retrovirus Vectors | 4/96 |
| 5,532,144
| Human Derived Monocyte Attracting Purified Peptide Products For Treating Human Infection And Neoplasms | 4/96 |
| 5,994,292
| Interferon-Inducible Protein 10 Is A Potent Inhibitor Of Angiogenesis | 4/96 |
| 5,990,088
| Method For Treatment Of Kaposi's Sarcoma (KS) By Antisense Oligonucleotides | 4/96 |
| 6,265,160
| Method Of Identifying Inhibitors Of The Jak-STAT Signal Transduction Pathway | 3/96 |
| 5,780,589
| Application of Highly Potent and Ultraselective delta Opioidmimetic Peptide Antagonists for Biochemical, Pharmacological, Clinical and Therapeutic Studies | 2/96 | 08/083,945 07/827,043
|
| AAMP-1 | 2/96 |
| 5,593,966
| Peptide Derivatives Of Cytochrome b558 And Their Use As Medicaments [As Anti-Inflammatory Agents] | 2/96 |
| 5,681,832
| Amido Substituted Stilbenes And Related Compounds With In Vitro Anti-HIV Activity | 2/96 | 08/479,039
| 5,663,167
| Antipsychotic Composition And Method For Treatment | 2/96 |
| 5,556,754 5,871,950
| Methods For Treating Autoimmune Diseases And Transplantation Rejection | 6/95 |
| 5,658,146
| An Improved Dental Abutment-Prosthesis Fastener | 6/95 |
| 5,519,534
| An Integrating Sphere Which Delivers A Homogeneous Beam Of Laser Light For Use In Photodynamic Therapy | 5/95 | E-134-1994
|
| Hepatitis C Virus Core Peptide For Stimulation Of Cytotoxic T Lymphocytes | 5/95 | 08/133,574 08/319,888 08/814,228 | 5,650,442 5,837,736 | Nitric Oxide-Releasing Compounds As Hypoxic Cell Radiation Sensitizers | 11/94 |
| 5,516,630 5,849,562
| Production Of Complementary DNA Representing Hepatitis A Viral Sequences By Recombinant DNA Methods And Uses Therefor | 11/94 |
| 5,610,198
| Novel Anti-Mycobacterial Compositions and Their Use for the Treatment of Tuberculosis and Related Diseases | 11/94 |
| 5,386,021 5,514,600
| Mammalian Guanine Nucleotide-Binding Protein with an ADP-Ribosylation Factor Domain (ARD1) | 11/94 | 08/188,325
| 5,483,958
| Fluorescent-Tipped Dosimeter Probe | 11/94 |
| 5,441,530 5,527,349
| Photochemotherapy Dosimeter | 11/94 |
| 5,498,719
| Diastereoselective Process Leading To A Key Intermediate For The Preparation Of Fluorinated Reverse Transcriptase Inhibitors | 11/94 |
| 5,711,296 5,429,127 5,305,740 | Continuous Positive Airway System | 11/94 |
| 5,716,816
| Clones Encoding Mammalian ADP-Ribosylarginine Hydrolases | 1/94 |
| 5,437,951 5,756,284 5,709,996 | Self-Assembling Recombinant Papillomavirus Capsid Proteins | 12/93 |
| 5,468,468 5,863,739 5,833,986 | Neutralizing Monoclonal Antibody To Human Alpha PDGF Receptors | 12/93 |
| 5,720,720
| Convection-Enhanced Drug Delivery System | 11/93 |
| 5,518,880 5,912,173
| Methods for Diagnoses and Treatment of XSCID | 4/93 | 08/330,865
| 6,060,334
| Anticancer Activity of Lovastatin and Related Compounds | 12/91 |
| 5,474,089
| Method And Device For Reversible Sterilization | 1/91 |
| 4,968,690 4,975,434
| 3-Deazaneplanocin, Intermediates for It, and Antiviral Composition and Method of Treatment Using It |
Back
|
|
|
|
|
|
![Spacer Spacer](https://webarchive.library.unt.edu/eot2008/20090117202746im_/http://ott.od.nih.gov/images/point.gif) |
|